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Abstract 
The eukaryotic MCM2-7 replicative helicase is a hetero-complex composed by 6 
homologues belonging to the AAA+ ATPase superfamily. These proteins form a 
ring-like structure which is essential for the initiation and the progression of the 
replication fork. In order to better understand the cellular role and mechanism of 
action of these proteins, I carried out structural and functional studies on two 
different systems: the archaeal MCM proteins, that forms a homomeric ring 
representing a simplified model of the eukaryotic complex, and the less well studied 
human MCM8, whose exact role in eukaryotic cells has not been elucidated. 
MCM interacts in two ways with the DNA: the canonical "loaded" mode where the 
MCM protein is encircling the DNA, and a "associated" mode where the DNA is 
wrapped around the enzyme. Using the protein from the archaeon 
Methanothermobacter thermautotrophicum, I biochemically shown that binding of 
MCM proteins affect the degree of supercoiling of dsDNA and that subdomain A is 
crucial for this interaction. To determine the structure of the C-terminal domain of 
the MCM proteins, the less studied region, I produced three different constructs 
corresponding to the C-terminus of the MCM proteins from M. thermoautotrophicum 
and Sulfolobus solfataricus. Despite a large effort using “high throughput” 
crystallisation techniques, no well diffracting crystals could be reproducibly 
obtained. An alternative structural biology approach has been adopted, using NMR 
analysis. Preliminary data are compatible with the bioinformatics prediction of a 
winged helix domain, but further work on isotope-labelled proteins is necessary for a 
full 3D characterisation. 
Two other MCM proteins have been more recently described (MCM8 and MCM9): 
they are present in a variety of eukaryotic organisms, do not interact with the 
MCM2-7 complex and their function in the cell is still unknown. These protein are 
co-evolutionary related and it is conceivable that they have a functional link. I cloned 
and expressed in E. coli cells a large number of hMCM8 fragments: two of them (the 
N-terminus and the AAA+ domain) can be successfully expressed in soluble form 
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and have been purified and used for biochemical assays. Both proteins forms dimers, 
bind ssDNA and the AAA+ catalytic domain displays ATPase activity. Further effort 
will be done to optimise the purification protocol to obtain proteins suitable for 
structural studies. In order to assess the hypothesis of a functional relationship 
between MCM8 and MCM9 proteins, a similarly extensive cloning strategy was 
applied to human MCM9, with the aim of obtaining constructs expressing a variety 
of fragments, to be co-expressed with the equivalent hMCM8 domains, and to test 
the formation of functional complexes. 
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1 Introduction. 
The replication of the genome must to be an exact process and requires a large 
number of proteins. Due to the large size of eukaryotic genomes, DNA replication 
starts at multiple sites along the chromosomes (called “origins of replication”). The 
entire process is tightly regulated to allow each origin to be used once for cycle and 
each fragment of the chromosome to be replicated only once. Errors in the control 
leads to disastrous consequence and can produce a large number of human genetic 
diseases, developmental abnormalities and cancer. The initiation step of the DNA 
replications is regulated by cell-cycle dependent kinases and a key target of these 
enzymes is the MCM2-7 complex (mini-chromosome maintenance). This protein 
assembly shares some functional and structural similarities with bacterial and viral 
helicases, as well as other initiation factors found in the three domain of life. 
My research project focuses on the biochemical and structural analysis of the 
eukaryotic MCM proteins and its simpler archaeal homologues. 
The MCM proteins are present only in proliferating cells and are highly expressed in 
malignant human cancer cells and pre-cancerous cells undergoing malignant 
transformation. Since they are not expressed in differentiated somatic cells that have 
been withdrawn from the cell cycle, MCM proteins are ideal diagnostic markers for 
cancer and possibly targets for anti-cancer drug development (Blow and Hodgson, 
2002). 
Here an overview of the DNA replication in bacteria, archaea and eukarya will be 
presented, followed by a summary of the recent functional and biochemical 
characterization of the eukaryotic MCM protein and their archaeal orthologues.  
1.1 The DNA replication begins. 
In all organisms DNA replication starts at particular genomic regions called 
"origins", that are recognized by protein initiator factors. The origins are defined by 
specific DNA sequences in prokaryotes, usually A-T rich zones prone to melting 
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called Duplex Unwinding Elements (DUE), or by secondary structure like in most of 
the eukaryotes. 
The protein factors that recognize the origin are also involved in the recruiting of 
other enzymes responsible for the firing of the replication fork and its progression. 
Most of the proteins that participate to this process are AAA+ ATPases (ATPases 
associated with various cellular activities), a family of enzymes which use the energy 
produced by ATP hydrolysis to perform mechanical work. The AAA+ proteins tend 
to form oligomers (often hexamers) with the nucleotide binding site at the interface 
of two adjacent subunits, so that elements from both subunits are involved in the 
ATP binding and hydrolysis process. 
1.1.1 In Bacteria 
The bacterial genome consists of a single circular chromosome with a single 
replication origin (oriC). An origin recognition protein (DnaA) recognizes consensus 
sequences repeats (DnaA boxes) in the origin, whose copy number varies from the 
organism to organism. The DnaA box/protein interaction has a 1:1 stoichiometry and 
the simultaneous recognition of adjacent DnaA boxes allows the protein 
oligomerization. DnaA has been shown to bend the DNA (Funnell et al., 1987; 
Schaper et al., 2000) and, under precise biochemical conditions, to mediate the 
melting of the DUE region (Speck and Messer, 2001). This model was based on 
direct topology footprinting evidence (Mizushima et al., 1996), and was confirmed 
by other biochemical and structural studies, suggesting that the ATP-bound DnaA 
stabilises positive supercoils (Erzberger et al., 2006). After DNA melting DnaB, the 
replicative helicase, is recruited at the origin by DnaC, the helicase loader. The ATP 
hydrolysis of DnaC after the correct loading of the helicase on the single stranded 
DNA (ssDNA), triggers the loader release and DnaB starts her unwinding work in a 
5'→3' direction. 
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1.1.2 In Eukarya 
More complex is the picture in the Eukarya; due to their large genomes, eukaryotic 
replication must begin simultaneously at multiple origins in order to be promptly 
performed. As an extreme example, during the early cleavage divisions of the 
Xenopus laevis embryos ~300,000 origins are activated (“fired”) which are ~10 kb 
from each other (Blow, 2001). 
The budding yeast Saccharomyces cerevisiae possesses well defined origins of 
replication, known as Autonomous Replicating Sequences, or ARS, bearing a 
conserved primary structure. This represents an exception, as in many cases the 
eukaryotic origins are without identifiable specific sequence (Sclafani and Holzen, 
2007), but seem to be defined by topology and dynamic chromatin structures 
(Rampakakis, 2009). Origins can be activated at different times on the S-phase of the 
cell cycle (early/late origins), in a CDK (Cyclin-dependent kinase) dependent and 
DDK (Dbf4-dependent kinase) dependent manner. 
In Eukarya, the origin are labeled by the Origin Recognition Complex (ORC), a 
protein complex composed by six different subunits (Orc1-6). Most of the ORC 
proteins belong to the AAA+ family (except for Orc6). In budding yeast ORC is 
bound to the origin throughout the cell cycle in a ATP-dependent manner, whereas in 
other organisms the binding is regulated by CDK. In the early G1 phase the Cdc6 
initiation factor (a AAA+ protein that share some similarity with Orc1) lands onto 
the ORC platform and is required for helicase loading. It has been proposed that a 
complex including Cdt1 and MCM2-7 is loaded onto ORC-Cdc6 complex during the 
initiation, forming the pre-replication complex (pre-RC) (Remus et al. 2009). At this 
point the origin is "licensed" and is ready to “fire” in the S-phase. After the 
dissociation of Cdc6 and Cdt1, ATP hydrolysis by ORC completes the MCM2-7 
loading. Sequential hydrolysis events, catalysed in turn by Cdc6 and ORC are 
required for binding and loading of multiple MCM2-7 complexes on each origin 
(Randell et al., 2006). 
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Once the pre-RC is formed, a number of other factors, like for example Sld3, Cdc45, 
MCM10 and all the proteins that compose the pre-loading complex (Sld2, Dpb11, 
GINS and Polε) are recruited onto the origin to form the pre-Initiation Complex (pre-
IC); S-CDK (S phase CDK) and DDK act locally at the origins during the S phase 
and play a major role in modulating the formation of the complex. First, MCM10 
(this proteins is not homologue of the MCM2-7 family) is recruited, leading to the 
stimulation of DDK activity (Lee et al., 2003), which phosphorylates the MCM2-7 
complex (Sclafani et al., 2002; Zou and Stillman, 2000). This post-translational 
modification event is believed to represent one of the major switches which initiates 
DNA replication. In yeast, a mutant of MCM5 (MCM5 bob1 mutant) which is able 
to bypass this event and promoting premature firing of the origin has been identified 
(Fletcher and Chen, 2006). 
S-CDK activity triggers the formation of the pre-loading complex (pre-LC) by 
phosphorylating Sld2 and Sld3 and promoting their binding to the phospho-binding 
BRCT domains of Dpb11  
Phosphorylated Sld3 not only binds the N-terminal BRCT domain of Dpb11, but also 
Cdc45: a factor which is required for the loading onto the replication bubble of 
polymerases and of the RPA protein (Replication Factor A, the eukaryotic single-
stranded binding protein, Aparicio et al., 1999). The role of pre-LC can be to recruit 
GINS and the leading DNA polymerase Polε at the origin and allow the formation of 
the Cdc45/MCM/GINS (CMG) complex (Tanaka and Araki, 2010). GINS (go, ich, 
nii, san complex) is a complex of four polypeptides comprising Sld5 and its partners 
Psf1, Psf2, Psf3. GINS association with the origins depends on Sld3-Dpb11 binding. 
What is the exact role of GINS in the CMG complex is still unclear: a speculative 
model has been proposed where GINS is acting like a ploughshare to sterically 
separate the two DNA strands (MacNeill 2010). MCM10 has been shown to directly 
interact with the Polα primase and to stimulate its catalytic activity (Fien and 
Hurwitz, 2006; Ricke and Bielinsky, 2004).  
Upon the formation of the pre-initiation complex (pre-IC), the MCM helicase is 
activated and, together with Cdc45, GINS and various polymerases, moves with the 
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fork. More factors are recruited to form the RPC (replication progression complex), 
as for example Top1 topoisomerase, the fork protection complex (composed by 
Mrc1/Claspin, Tof1/Tim and Csm3/Tipin.), Ctf4/And-1, etc.  
What has been discussed so far is an overview of the budding yeast S. cerevisiae 
initiation and elongation steps (Figure 1.1). Although this represents a good model, 
there are differences between various eukaryotic organisms and for some of the 
players the counterparts in higher eukaryotes have not been yet identified. In fission 
yeast as in metazoans the replication origins lack consensus sequence, but they 
contain often AT-rich region. In Schizosaccharomyces pombe the ORC complex has 
an extra DNA binding domain (located at the N-terminal of Orc4) that seems to be 
important for the recognition of this AT-rich elements (Sun and Kong 2010). 
S. pombe ORC does not require ATP to bind the DNA.  
Dpb11 homologous are found in fission yeast (Cut5) as well as plants and metazoans 
(human TopBP1 and Drosophila Mus101). These homologues are more complex and 
possess more BRTC domain. In Xenopus Cut5 (xCut5) is required for the transition 
from pre-RC and pre-IC. A possible functional analogue of Sld2 in human cells may 
be the RecQL4 helicase, whose N-terminal region shares some sequence homology 
with Sld2. This protein seems to be essential for replication, and in Xenopus is able 
to interacts with xCut5. However, unlike Sld2, RecQL4 appears to function after 
Cdc45 and GINS loading onto replication origins (Pospiech et al., 2010).  
More open is the debate as to the analogue of Sld3 as, in the last year, three different 
proteins have been suggested as putative homologues of Sld3 in metazoans: DUE-B 
(DNA Unwinding Element Binding), Treslin/Ticrr (TopBP1-interacting replication-
stimulating protein), and GEMC1. Sanchez-Pulido and colleagues (2010) show that 
significant sequence homology does exist between Treslin/Ticrr and Sld3, suggesting 
an orthologous evolutionary relationship between these two proteins. Like Sld3, all 
three proteins can be found in a complex with TopBP1, have been connected to CDK 
activity and they all function specifically at the Cdc45 loading step. At least one of 
these (GEMC1) was found to be a bona fide CDK target. However, the binding of 
Treslin/Ticrr to pre-RC itself is not CDK-dependent, as for Sld3. One possibility is 
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that in higher eukaryotes the functions of Sld3 in replication initiation has been taken 
up by several proteins, not necessarily all related by sequence to Sld3. This would 
provide to metazoan organisms more CDK targets in replication initiation, allowing 
for additional regulatory inputs into this crucial event. Another possibility is that 
DUE-B or GEMC1 performs Sld2‟s role in CMG assembly. In this regard it is 
interesting that the recruitment of DUE-B to pre-replication complexes is Cdk2-
dependent, which also appears to be the case for Sld2 (as reviewed by YV. Fu and 
JC. Walter, 2010). Moreover, in metazoans it has been demonstrated that Cdc45 can 
directly interacts with Dbp11/Cut5/TopBP1 (Pospiech et al., 2009). 
Cell cycle regulation of DNA replication  
All the steps described above are strictly regulated in a cell cycle dependent manner. 
The assembly of pre-RC takes place at late M and early G1 phase when CDK activity 
is low, whereas high CDK activity (in S, G2 and early M phase) prevents the 
formation of the preRC as most of the proteins that forms the pre-RC can be 
phosphorylated and phosphorylation inhibits their activity.  
The phosphorylation of Sld2 and Sld3 by S-CDK (see previous paragraph) is 
necessary and sufficient for the establishment of the replication fork (Tanaka and 
Araki, 2010). The essential target(s) of DDK is still unknown. 
The expression profile or the location of the essential factors in the cell can be a 
further way to control the initiation of replication. In S. cerevisiae Cdc6 is only 
expressed in G1 and is degraded in the other phases of the cell cycle, whereas Cdt1 
and MCM protein are present in the nucleus only in late M, G1 and S. After 
replication is initiated those proteins are exported into the cytosol. In fission yeast 
Cdc18, the homologue of Cdc6, and Cdt1 are present only in G1 and are then 
degraded (Sun and Kong, 2010).  
In metazoans there are some extra regulation processes to inhibits the pre-RC 
formation in S and G2 phase, as for example accumulation of the replication 
inhibitor Geminin, a protein which sequesters the Cdt1 factor, therefore preventing 
MCM2-7 from being loaded (McGarry and Kirschner, 1998). 
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In G1-phase MCM2-7 is transported at the origin in a complex with Cdt1, to form 
the pre-RC. Upon the S-phase the helicase is activated by DDK, that phosphorylates 
the MCM2, MCM4 and MCM6; this post-transcriptional modifications may trigger 
the conformational change needed to activate the helicase. In S. cerevisiae a MCM5 
mutant (bob1) that is able to bypass the phosphorylation event, promoting premature 
firing of the origin replication, has been identified: probably this mutant (involving a 
Pro->Leu mutation at position 83) mimics the "active configuration" of the enzyme.  
The MCM complex can also be modulated during the elongation step, as the collapse 
of the replication fork due to double-strand breaks triggers a S-phase checkpoint 
cascade that blocks the elongation until the problem is fixed. How the mechanism 
works is unclear, but the interaction of the helicase with the “fork protection 
complex” seems to be indispensable to stop the DNA unwinding. 
1.1.3 In Archaea 
Despite their morphological similarity to Bacteria, the DNA replication apparatus of 
Archaea shares lots of similarities with the eukaryotic replisome. Archaea are 
therefore used as a eukaryotic model, because their enzymes involved in DNA 
metabolism resemble a simpler version of the eukaryotic ones (Kelman and Kelman, 
2003). For example the eukaryotic helicase MCM2-7 is an heterohexamer composed 
by 6 paralogues, whereas in the majority of Archaea there is only one gene encoding 
for a MCM-like protein, generating a homo-multimeric functional helicase. 
All archaeal genomes contain at least a gene that encodes for a protein which shares 
homology with both eukaryotic Cdc6 and Orc1 and is variably referred to as Cdc6, 
Orc1 or Cdc6/Orc1 protein. In this work I will use the Cdc6 nomenclature. 
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Figure 1.1 Schematic representation of the initial steps of eukaryotic replication. During the G1 
phase of the cell cycle the pre-RC (constituted by ORC, Cdc6, Cdt1 and MCM) is recruited at origins 
of replication. Upon DDK and CDK mediated activation, a number of additional factors are recruited, 
to form the pre-initiation complex. These include MCM10, Cdc45, GINS, Sld2, Sld3 and Dpb11. The 
spatial organization and the stoichiometry of these factor is unclear as observation made in different 
species do not give a consistent picture. During the elongation phase of DNA replication a complex 
made of MCM, GINS and Cdc45 has been found to travel together with the replisome. 
The archaeal genome is a single chromosome with varying number of DNA 
replication origin, ranging from one up to five like for Haloferas volcanii (Norais et 
al., 2007). In a study on Sulfolobus solfataricus, a number of specific DNA 
sequences (Origin Recognition Boxes, or ORB) have been identified within three 
origins of replication (named oriC1-3), which are recognized by different Orc1/Cdc6 
factors: Cdc6-1, Cdc6-2 and Cdc6-3, (Robinson et al 2004). The ORB elements are 
usually found flanking the DUE sequence and the interaction with the Cdc6 may 
impose a topological stress that facilitates the melting of the AT rich zone. Cdc6 
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bound to the DNA will be the landing platform for the other proteins involved in the 
formation of the pre-RC.  
The crystals structures of various archaeal Cdc6 orthologues are available: a 
monomeric structure of the Pyrobaculum aerophilum Cdc6 and Aeropyrus pernix 
Cdc6-2 (Liu et al., 2000; Singleton et al., 2004). These structures highlight that the 
Cdc6 proteins comprise two candidate regions for the interaction with DNA: an 
helical insertion (ISM) in between the Walker A and Walker B sequence motifs and 
a winged helix (WH) C-terminal region. Later on the crystallographic structures of 
an heterodimeric complex from S. solfataricus composed by Cdc6-1/Cdc6-3 (Dueber 
et al., 2007) and a monomeric A. pernix Cdc6 (Gaudier et al., 2007) bound to nucleic 
acid (an ORB element) were published. In both structure the proteins bound an ORB 
elements, and the Cdc6 initiator factors clamp around and distort the DNA, 
contacting the double helix via the two motives previously described. 
In Archaea the Cdc6 proteins may can also act as the helicase loader; biochemical 
studies show that they have properties similar to the bacterial DnaC interacting with 
helicase. In Methanotermobacter thermoautotrophicum the C-terminal WH of Cdc6 
interacts with the N-terminal region of MCM destabilizing the ring and probably in 
this way promoting the loading of the helicase onto the origin. This interaction 
cannot be detected using the full length MCM protein (Kasiviswanathan et al., 2005), 
possibly suggesting that a conformational change is needed (which occurs more 
easily in the N-terminal domain alone), or that another initiator factor is required 
(Gautier et al., 2007, Kasiswanathan et al., 2005). A potential candidate is the WhiP 
initiator factor, a divergent Cdt1 homologue discovered in S. solfataricus, whose 
binding to origins of replication is stimulated by Cdc6-1 and Cdc6-2 (Robinson and 
Bell, 2007). The WhiP protein may works in a way similar to the bacterial plasmid 
initiator RepA, suggesting that this factor may play a critical role in the stabilization 
of the archaeal initiator/helicase heteromeric complex (Figure 1.2). 
The interaction with Cdc6-like proteins may be a mechanism of MCM regulation, as 
in M. thermoautotrophicum and in S. solfataricus the helicase activity of MCM is 
affected and inhibited by Ccd6 binding, that can destabilize the hexameric ring. This 
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can be also the way for promote the MCM loading at the origin. On the other hands 
in Thermoplasma acidophilum MCM activity (helicase and ATPase) is stimulated by 
Cdc6 interaction (Sakakibara et al., 2009). 
How DNA replication is initiated is not yet understood and only in the last few years 
archaeal homologues of the GINS proteins have been identified by sequence analysis 
(Makarova et al., 2005). In all archaea a protein with sequence similarity to both 
Sld5 and Psf1 can be identified (GINS15), whereas a gene coding for a protein 
homologous to Psf2 and Psf3 (GINS23) is found in the Crenoarchaeota (such as 
S. solfataricus) and in a subset of Euryarchaeota (such as the Thermococcales, i.e. 
Pyrococcus furiousus). When two GINS proteins are found, biochemical studies 
show that two copies of each seem to be present, generating a quaternary structure 
similar to the eukaryotic tetramer. No information has been published on the 
stoichiometry of the archaeal single GINS15 proteins. No obvious archaeal 
homologues of Cdc45, Sld2, Sld3, Dpb11 and Mcm10 have been detected to date 
(MacNeill, 2010).  
Yeast two-hybrid experiments using S. solfataricus proteins have shown that 
GINS23 interacts with the N-terminal region of the MCM complex and with the 
DNA primase (Marinsek et al., 2006); whereas the P. furiosus GINS complex 
interacts with a Cdc6 protein (Yoshimochii et al., 2008), suggesting that GINS is 
involved in the initiation as well as the elongation step of the DNA replication. 
The biochemical effect of the GINS/MCM interaction in Archaea may be species 
specific, as in P. furiosus GINS was shown to stimulates the MCM helicase activity, 
whereas no stimulation is detectable in S. solfataricus. 
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Figure 1.2. Schematic representation of the putative steps in the initiation of archeal DNA 
replication. A) the ORB elements (orange boxes) are recognized by Orc1/Cdc6 protein, B) the MCM 
complex is loaded at the origin and Whip is stabilizing the interaction between Cdc6 and MCM, C) 
the topological stress produced by the proteins/dsDNA interaction may contribute to the formation of 
the replicative bubble. 
Chapter 1 Introduction 
12 
 
1.2  What we know about MCM protein. 
The minichromosome maintenance (MCM) proteins were first identified in budding 
yeast as temperature sensitive mutants defective in the maintenance of 
minichromosomes, and were subsequently shown to play a crucial role in plasmid 
replication and cell cycle progression (Tye, 1999; Forsburg, 2004). Eukaryotic cells 
contain six conserved MCM polypeptides, named MCM2, MCM3, MCM4, MCM5, 
MCM6 and MCM7, which form a multiprotein complex (MCM2-7). MCMs are 
AAA+ proteins ranging from 600 to 1200 residues, and they are essential for the 
initiation and progression of the replication fork (Figure 1.3).  
The eukaryotic MCM proteins have been shown to be chromatin-bound in the G1 
phase, displaced during replication in S phase, and absent from chromatin in the G2 
phase (Diffley and Labib, 2002; Stillman, 2005). The regeneration of replication 
competence is associated with a new binding event of MCMs to chromatin at the end 
of mitosis (Blow and Dutta, 2005). Although a large body of evidence suggests that 
MCM2-7 is involved in DNA unwinding, for a long time no helicase activity was 
detectable for the MCM complex, with only a weak unwinding activity associated 
with the MCM4/6/7 sub-complex. This sub-complex, forming an hexameric ring, as 
suggested by size exclusion chromatography and EM imaging (Bochman and 
Schwacha, 2007), has an ATP-dependent 3' 5' helicase activity and a preference for 
ssDNA than dsDNA.  
A stable complex including MCM2-7 as well as Cdc45 and GINS, can be purified 
from Xenopus embryo extracts and displays an ATP-dependent helicase activity 
(Moyer et al., 2006), thus suggesting that Cdc45 and GINS are essential cofactors. 
This study has been recently confirmed by the assembly of a catalytically active 
Drosophila CMG complex in baculovirus-infected insect cells (Ilves et al. 2010). In 
a parallel effort, a biochemical study identified specific buffer conditions in which 
the helicase activity of the recombinant human MCM2-7 complex alone is 
measurable. The presence of glutamate facilitates the Mcm2-7 helicase activity, with 
glutamate likely displacing inhibitory anions, such as chloride ions. Since DNA is 
itself negatively charged, helicase stimulation cannot involve the binding of 
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glutamate to DNA. Moreover, since glutamate changes the ability of Mcm2-7 to bind 
different topological forms of ssDNA rather than changing its affinity for ssDNA, 
glutamate likely facilitates a conformational change in the complex. The finding that 
glutamate mimics many of the effects of ATP, a known Mcm2-7 substrate, further 
suggests the physiological relevance of the effects of glutamate (Bochman and 
Schwacha 2008). Although chloride is commonly present in many in vitro enzymatic 
reactions, it is not the major cellular anion in eukaryotes (see Leirmo et al., 1987 and 
references therein) 
In archaeal genomes there is at least one gene encoding for a functional MCM 
paralogue, which can form homoligomers, and has been extensively studied as a 
model to understand how the replicative helicase works. The archaeal complex 
displays a robust 3' 5' helicase activity dependent on Mg
2+
 and ATP hydrolysis 
(Kelman et al., 1999; Chong et al., 2000; Shechter et al.,2000 Carpentieri et al., 
2002). The S. solfataricus MCM, as well as the MCM from Archeoglobus fulgidus 
and A. pernix, has a preference for binding bubble or Y-shaped DNA substrates. A 
large number of biochemical studies have been carried out on those proteins, 
elucidating the role of the separate domains (Kasiviswanathan et al., 2004; Barry et 
al., 2007; Pucci et al., 2007), of various functional elements (McGeoch et al., 2005; 
Jenkinson and Chong, 2006; Sakakibara et al., 2008; Barry et al., 2009, Brewster et 
al., 2010), as well as specific residues (Pucci et al., 2004; Moreau et al., 2007; 
Jenkinson et al., 2009) in DNA binding, ATPase and helicase activity (Sakakibara et 
al., 2009). 
Other two MCM proteins have been described in higher eukaryotes and called 
MCM8 and MCM9; more detailed bioinformatics analysis demonstrated that these 
proteins are actually widespread in eukaryotic organisms.  
Another protein with some weak homology to the MCM family, named MCM-BP 
(MCM binding protein), was shown to co-precipitate with and MCM3-7 complex in 
human cells, therefore substituiting MCM2, but nothing is known about its function 
(Sakwe et al., 2007). 
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Figure 1.3. Schematic representation of eukaryotic and archaeal MCM protein. In Eukarya eight 
different genes are found, encoding for eight paralogues with a highly conserved AAA+ catalytic 
domain, whereas in the majority of Archaea there is a single gene encoding for a functional MCM 
protein, forming a homo-oligomer. 
1.2.1 MCM structures 
A canonical MCM protein can be divided into three regions: the N-terminal (N-term) 
domain, the AAA+ catalytic domain and a winged helix (WH) C-terminal domain 
(Figure 1.4).  
Biochemical data show that the N-term binds both single stranded and double 
stranded DNA, is a determinant for the hexamerization and influence the processivity 
and the polarity of the helicase. Two crystal structure of this region are available: one 
from the MCM of the euryarchaeon M. thermoautotrophicum (MthMCM-N) 
(Fletcher et al.,2003) and the second from the crenarchaeon S. solfataricus 
(SsoMCM-N) (Liu et al., 2008). 
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Figure 1.4 The architecture of MCM proteins. A) The primary structure of a tipical MCM protein 
can be divided into a N-terminal domain (green), a AAA+ domain (red) and a C-terminal domain 
(blue). The N-terminal domain can be further subdivided into three subdomains and includes 
functional elements, such as the Zn motif, N-terminal β-hairpin (NBH) and ACL loop. The AAA+ 
domain folds into an α/β subdomain (red) and an α domain (orange); the former contains the Walker 
A, Walker B, sensor I and R finger motifs found in AAA+ protein, as well as the unique insertions 
(EXT, h2i and PS1BH) which characterize MCM; the latter contains the sensor II motif. The helical 
linkers connecting the N-terminal-AAA+ domains, and the α/β - α domains are shown in dark gray 
and light gray, respectively. The C-terminal domain is predicted to fold into a winged helix (WH) 
motif. B) Schematic diagram of the putative MCM2-7 hexamer, showing the relative position of 
MCM proteins, as derived from biochemical data (Crevel et al., 2001; Davey et al., 2003; Bochman et 
al., 2008). 
The first one crystallises as a double hexamer with a head-to-head orientation, 
whereas the second as a single hexamer (Figure 1.5). Both present a central 
positively charged channel that can accommodate a single strand of DNA (ssDNA), 
but the channel of MthMCM-N is large enough to also encircle a double stranded 
DNA (dsDNA). It is possible that the N-term region preferentially binds ssDNA or 
that the SsoMCM-N has been trapped in an inactive conformation.  
The N-term can be divided into three subdomains (sA, sB and sC) and their 
biochemical functions have been extensively characterized. Subdomain A is the 
peripheral belt of the ring and is involved in the regulation of the helicase activity, so 
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that when this region is missing MCM is a more processive helicase. Subdomain B, 
at the interface of the double ring in the dodecameric MthMCM-N structure, contains 
the Zn motif that contributes to DNA binding, as deletion of this domain impair 
ssDNA binding but not helicase activity. Subdomain C is responsible for the 
hexamerization and contains a β-hairpin (NBH) that protrudes towards the center of 
the channel and also participate to DNA binding (Kasiviswanathan et al.,2004; Barry 
et al., 2007). Subdomain C also comprises the ACL loop (allosteric communication 
loop, Sakakibara et al. 2008; Barry et al., 2009), highly conserved in archaeal and 
eukaryotic MCMs; this loop has an important role in the communication between an 
N-term and the adjacent AAA+ domain in the hexameric ring. 
Various lines of evidence, based on structural analysis of the N-term suggest that this 
domain may undergo large conformational changes. The crystal structure of a single 
mutant in the MthMCM (Proline 61 to Leucine) that mimics the MCM5 bob1 in 
yeast (Fletcher et al., 2003), mutation that can bypass the DDK phosphorylation 
event for the activation, has a more open sA. This small movement is also confirmed 
by the 3D EM reconstruction of the N-terminal domain alone, where the sA is 
drastically open. A less dramatic swing out movement of sA is also evident when 
superimposing the two N-term crystals structure, with the SsoMCM-N having sA in a 
more “open” configuration (Costa et al., 2008).  
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Figure 1.5 The crystal structure of the N-terminal domain. A) A side view of the dodecameric 
structure of M. thermautotrophicus MCM (Fletcher et al., 2003) and B) of the hexameric structure of 
S. solfataricus MCM (Liu et al., 2008). C) Each monomer folds into three subdomains: subdomain A 
(sA, yellow) is located in the outer belt of each ring; subdomain B (sB, in teal), coordinates a zinc 
atom that is located at the interface between the two hexameric rings; subdomain C (sC, in green) is 
responsible for the inter-subunit contacts within a hexamer. The structural elements that are important 
for the activity of the protein are highlighted in red. A dashed line indicates the position of the six-fold 
axis around which the hexameric complex forms. D) and E) Surface representations of the MthMCM-
N and SsoMCM-N hexamers (in green and cyan, respectively) highlight the differences between the 
two structures, especially regarding the size of the internal channel.  
The central AAA
+
 domain folds into two subdomains: an α/β subdomain and a α 
domain (also called “lid” domain). This region alone can form an hexamer and 
possesses DNA helicase activity. The catalytic domain contains the Walker A (WA), 
Walker B (WB), sensor I, sensor II and Arginine finger signature sequence motifs 
typical of AAA+ ATPases. All these motives are required for the ATP binding and 
hydrolysis (Figure 1.4).  
In the last year structural information for two full-length MCM proteins has become 
available, providing a model for the AAA+ domain. One is the structure, solved at 
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high resolution (1.9 Å), of an unusual, inactive and monomeric MCM from 
Methanopyrus kandleri (MkaMCM2) (Bae et al., 2009); this protein is lacking the 
majority of the functional motives, including subdomain B, WA, WB, sensor I and R 
finger as well as the C-term region. The second structure is a monomeric (almost) 
full length SsoMCM, since for the C-term region only weak and partial electron 
density was detectable; this structure was solved at much lower resolution (4.35 Å) 
but gives us a picture of a functional MCM (Brewster et al., 2008). Both monomeric 
structure can be superposed on the MthMCM-N to construct the hexameric ring 
(Figure1.6). 
As predicted from structural comparisons (Erzberger and Berger, 2006) and 
biochemical studies on the trans nature of the sensor II (Moreau et al., 2007), due to 
the insertion of a helix at the end of the α/β-domain, α/β domain and α domains 
present a different relative arrangement compared to a classical AAA+. In this 
protein the α domain is acting in trans and interacting with the ATP of the neighbour 
active site: in fact the sensor II protrudes in the active site of the adjacent subunit 
(Figure 1.7).  
MCM proteins are characterised by an insertion in the α/β subdomain occurring 
before the sensor I motif and forming a β-hairpin. This insertion has been called the 
pre-sensor-1 β-hairpin (PS1BH) and defines a superclade of the AAA+ superfamily. 
Within the PS1BH superclade, a number of AAA
+
 proteins, including MCM, contain 
an additional insertion disrupting the continuity of helix 2 (Iyer et al., 2004). The 
helix 2 insertion (h2i) and the PS1BH are critical for DNA unwinding (Jenkinson and 
Chong, 2006; Barry et al., 2007). 
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Figure 1.6 Structural models of the archaeal MCM helicases. A) The crystal structure of the 
MCM2 of Methanopyrus kandleri (Bae et al., 2009). The sequence is unusual for an MCM protein, as 
it does not have subdomain B and the C-terminal domain, and lacks a number of conserved elements, 
such as ACL, NBH, WA, WB, PS1BH and R finger. The protein is a monomer in solution and in the 
crystal. The AAA+ domain folds into two subdomains (α/β in red and α in orange) and is connected to 
the N-terminal domain through a long loop wrapping around the AAA+ domain and a couple of 
helices (dark gray): the N–C connection is intertwined with another helical extension (light gray – 
partially disordered in the structure) that links the α/β and αdomains. A hexamer can be built based on 
the symmetry of the MthMCM-N structure B) The crystal structure of the MCM of 
Sulfolobus solfataricus (Brewster et al., 2008). The C-terminal domain is disordered in the crystal and 
no atomic model could be built. The color code for the monomer is the same as in figure 4. Although 
the protein can form a hexamer in solution, a monomer is present in the crystal; a hexamer can be built 
based on the symmetry of the MthMCM-N structure. 
The EM maps (Bae et al., 2009) and the modelled hexameric ring also shows the 
putative interaction between the PS1BH of one subunit and the ACL loop of the 
adjacent subunit, interaction that is responsible both for the communication between 
N-term and AAA+ domain and between adjacent subunits.  
The crystal structure of the SsoMCM reveals a conserved external loop (EXT) at the 
lateral hole and mutants of this loop are defective in the helicase activity and DNA 
binding (Brewster et al., 2008; Brewster et al., 2010). 
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Figure 1.7 The unusual architecture of the MCM AAA+ hexamer. A) The interface between two 
subunits within a hexamer as seen in the crystal structure of the bacterial transcriptional enhancer 
PspF bound to ATP (Rappas et al., 2006) shows the arrangement seen in the majority of AAA+ 
proteins. In one subunit the α/β domain is in red, with the α domain in orange, whereas in the adjacent 
subunit the the α/β domain is in blue, with the α domain in cyan; the sensor II arginine highlighted in 
green; the ATP molecule at the interface between subunits is shown. As schematically illustrated in 
the diagram, the ATPase active site at the interface between the red and blue subunit is made up of 
residues mostly belonging to the blue subunit, including Walker A (A), Walker B (B), sensor I, and 
sensor II (II, in green) acting in cis, whereas the arginine finger (R) is contributed in trans by the α/β 
domain of the next-neighboring subunit. B) The same inter-subunit interface is shown for a hexameric 
model derived from the crystal structure of SsoMCM-FL (Brewster et al., 2008) overlapped on the 
MthMCM N-terminal domain structure (Liu et al., 2008). The same color code as for PspF is used; in 
addition the connection between the N and C-terminal domain is shown in dark gray, whereas the 
MCM peculiar insertion between the α/β and α domains is shown in light gray. The effect of this 
helical insertion is to dramatically reposition the α/β domain so that it is now located at the adjacent 
interface. The diagram illustrates how the active site now comprises the Walker A, Walker B, sensor I 
residues from one subunit (in cis) and the R finger and sensor II from the adjacent subunit (in trans). 
Similarly to the N-term region, also the AAA+ domain may be flexible. The 
conformational changes of the subunits can be caused by ATP or DNA binding, as 
well s ATP hydrolysis.  
Due to the lack of crystallographic data, most of the evidence for these 
conformational changes comes from single particle electron microscopy (EM). 
Analysing the 3D EM reconstruction of the MthMCM with different substrate is 
possible to visualise changes in the stoichiometry of the ring (seven subunits in 
presence of nucleotides or six subunits in presence of a fragment of dsDNA of 100 
base pairs). In the presence of dsDNA the central channel is partially occupied by 
peaks of electron density. By fitting the AAA+ domain structure into the EM map, 
this electron density can be modelled by the h2i protruding into the middle of the 
channel (Figure 1.8). The change in the thermostability of the MthMCM when the 
protein is bound to the substrate is another evidence for substrate-induced 
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conformational changes (Sakakibara et al., 2009). Mutagenesis studies of the PS1BH 
in SsoMCM and of the h2i in MthMCM (McGeoh et al., 2005; Jenkinson and Chong 
2006) demonstrate that those motives are crucial for the DNA binding and the 
helicase activity; it has been suggested that the h2i protruding in the central channel 
could interact with the nucleic acid and allow the separation of the strands using a 
conserved aromatic residue as ploughshare (Costa and Onesti, 2009). 
 
Figure 1.8 3D EM reconstruction of MthMCM. A) Surface rendering of double-ring structures of 
MthMCM from negatively stained samples in the presence of substrates (Costa et al., 2006a). On the 
left (in yellow) a side view of the ADP·AlFx treated double heptamer showing a head-to-head double-
ring configuration with lateral holes, and a slice through the center, showing the large uninterrupted 
channel through the molecule. On the right a side view and a slice-through of the protein treated with 
100 bp of dsDNA (in blue). The protein forms a double hexamer with a strong asymmetry between 
the two rings. The upper ring is closed on top by a cap, and has the central channel obstructed by a 
peak of electron density, whereas the bottom ring is hollow and uncapped. Seven-fold and six-fold 
symmetry, respectively, were applied to the reconstructions. C) A section through the middle of the 
upper rings in both structures shows the striking features of the dsDNA-treated protein, with a peak of 
electron density connected to the ring by six protrusions. B) and D) Fitting of atomic models to the 
double hexameric EM map. The dodecameric MthMCM-N atomic coordinates (Fletcher et al., 2003) 
were fitted to the central part of the molecule (in green). For the AAA+ tier of the lower ring the 
SsoMCM-FL structure (Brewster et al., 2008) arranged into a hexamer based on the MthMCM-N 
model matches well the electron density (in red). C) and D) To fit the upper ring, a rigid body rotation 
needs to be applied to the AAA+ domain. The reorientation of the AAA+ domain in the top ring 
brings the helix-2 insertions (in yellow) towards the central channel, fitting into the lateral protrusions. 
The PS1BH elements are shown in yellow. 
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Sequence analyses predicts a winged helix (WH) motif in the C-terminal region of 
the archaeal enzymes. This prediction was recently confirmed, as the C-term region 
of the human MCM6 has been determined by NMR confirming a winged-helix fold 
made up of three helices and two β-strands (Figure 1.9). Winged helix proteins 
belong to the HTH family, typically including DNA-interacting domains, but no 
biochemical evidences for DNA binding by the C-terminal domain were found for 
SsoMCM (Barry et al., 2007) nor for the MCM6 C-terminal domain (Wei et al., 
2010), although the deletion of this region leads to reduction of the DNA binding 
(Kasiviswanathan et al., 2004, Costa et al., 2008). C-term deletion mutants are also 
better helicase and ATPase, suggesting a possible regulatory activity but the exact 
role of this region is still unknown. However its importance is clear, since in vivo 
studies on the MCM of H. volcanii showed that most of the mutations involving the 
C-terminal domain were lethal (McNeill, unpublished result). 
 
Figure 1.9 NMR structure of hMCM6-CBD. A) The backbone superposition of the 20 lowest-
energy NMR structures of Mcm6-Cdt1 Binding Domain. Secondary structural elements are indicated 
by color coding: α helices (red), β-strands (green), and loops (cyan, gray). N-terminal and C-terminal 
ends are indicated as N and C. B) a ribbon representation of the same structure of CBD using the 
coordinates of the lowest energy structure 
Different locations have been proposed for the C-terminal domain. In a double 
hexamer 3D reconstruction electron density occupying the central channel was 
suggested to be due to the C-term (Gomez-Llorente et al., 2005). A more recent and 
detailed study from our laboratory, comparing EM data for the full-length and a C-
terminal deleted MCM protein, shows that the C-term region is likely to be located 
on top of the AAA
+
 domain (Costa et al., 2006, Costa et al., 2008) (Figure 1.10). 
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Figure 1.10 Location of C-term domain in MthMCM.  On the left, in magenta, the cryoEM 
structure of the C-terminal deletion mutant, on the right the superposition of the wt (blue) and ΔC 
(magenta) maps (Costa et al., 2008): the two are very similar, except for the protrusions on the top of 
the molecule (highlighted by the dashed blue line) which are only present in the wt map 
The MCM protein are really polymorphic; a good example is the MthMCM. 
Different 3D EM reconstruction demonstrated that MCM can form single hexamers 
(Pape et al., 2003) or heptamers (Yu et al., 2002), as well as double hexamers or 
double heptamers (Gomez-Llorente et al., 2005; Costa et al., 2006a). The presence of 
substrates controls the stability and the stoichiometry, with short dsDNA fragments 
triggering the formation of head-to-head double hexamers, and nucleotides the 
formation of double heptamers (Costa et al., 2006a&b, Jenkinson et al. 2009). 
Double rings are seen in size exclusion chromatography, but they are probably 
unstable and not visible by EM when the protein is free from substrate.  
But this protein can be also found in fibrous helical structures, where the orientation 
of the particles is “head-to-tail”. Deletion of the N-terminal subdomain A strongly 
encourages the formation of helices (Chen et al., 2005) (Figure 1.11). Biochemical 
analysis have underlined as a certain degree of polymorphism may be dependent on 
the temperature and salt concentration (Shin et al., 2009).  
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Figure 1.11 Polymorphism of MthMCM as visualised by electron microscopy studies: A) single 
heptamer (Yu et al., 2002); B) single hexamer (Pape et al., 2003); C) helical fiber (Chen et al., 2005); 
D) R137A mutant double heptamers (Jenkison et al., 2009); E) double hexamer in the presence of  
100 bp dsDNA; F) double heptamer in the presence of the nucleotide analogue ADP-AlFx (Costa et 
al., 2006). 
A recent 3D EM reconstruction of the S. cerevisiae MCM2-7 loaded onto DNA 
shows a structure compatible with the reconstruction of the MthMCM complexed 
with dsDNA (Figure 1.12) (Remus et al., 2009). In this paper the authors are able to 
reproduce in vitro the assembly of the pre-RC and the helicase is loaded as a double 
hexamer (resistant to high salt washes) and able to translocate along a small plasmid. 
This strongly suggests that eukaryotic MCM are loaded onto the origin as double 
hexamers, with a head-to-head orientation.  
As in the archaeal orthologue, lateral holes are visible in the MCM2-7 structure, as 
well as a central channel that can encircle a dsDNA (Remus et al., 2009). The length 
of the complex is consistent with footprinting experiments carried out on the 
MCM4/6/7 complex indicating that the protein protects a DNA region corresponding 
to the size of a double hexamer (You and Masai, 2005) as well as with the size of the 
pre-replicative footprinting (Santocanale and Diffley, 1996; Labib et al., 2001). 
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Figure 1.12 Three-Dimensional Reconstruction of the Mcm2–7 Double Hexamer. A-B) Surface 
representations of a 3D reconstruction of the Mcm2–7 double hexamer filtered to 30 Å at the 
predicted molecular weight for the Mcm2–7 double hexamer. C) Cut-open side view (from Remus et 
al., 2009). 
1.2.2 Mechanism of action 
All the MCM proteins studied can bind and translocate along duplex DNA. It is not 
yet clear whether the protein is active as a single or double hexamer.  
Whether the double hexamer has simply a role in the initial stage of DNA replication 
(helicase loading, initial melting), or is necessary for the helicase activity, remains to 
be established.  
Still unknown is the physiological significance of the heptameric and double 
heptameric rings that are seen in the archaeal MCMs. One possibility is that the 
heptamer is an in vitro artefact, however, the formation of double heptameric rings is 
systematically triggered in the MthMCM system by the addition of ATP analogues, 
such as AMP-PNP and ADP·ALFx (Costa et al., 2006b). Heptameric rings are also 
stabilized by mutations at the very bottom of subdomain B; in particular the R137A 
mutant shows a double heptamer configuration with a remarkable swing-out of 
subdomain A in one of the two rings (Jenkinson et al., 2009, Figure 1.11 D) . It is 
possible that the mutation “traps” a more labile transient intermediate state that is 
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necessary for the loading of the complex onto DNA. Although it is more difficult to 
extend this model to the eukaryotic hexameric MCM2-7, initial data on EM analysis 
of MCM complexes purified from eukaryotic cells shows hints of heptameric 
symmetry. This observation, although still very preliminary, has been made 
independently by two different groups (Remus et al., 2009; S. Onesti, A. Patwardhan 
and J. Blow, unpublished observations) working on two diverse eukaryotic systems. 
Further work is required to confirm the result and establish the biochemical nature of 
the putative heptamer.  
Role in the initiation of DNA replication  
MCM2-7 proteins have been shown to interact with chromatin in two different ways: 
as a labile “associated complex” that is disrupted by high salt washes, and as a 
“loaded complex” that is salt-resistant (Donovan et al., 1997; Bowers et al., 2004). 
The identification of an unexpected modality of contact between MCM and dsDNA, 
with the nucleic acid wrapping around the N-terminal half of the protein (Costa et 
al., 2008) may provide a structural model for the associated complex.  
The topological changes in the DNA that are a consequence of this interaction could 
assist the first steps in origin melting by changing the degree of supercoiling of the 
adjacent DNA regions, and hints at the possibility that MCM proteins may be 
actively involved in the initiation of DNA replication (Costa and Onesti, 2008). 
MthMCM proteins have also been reported to form fibrous and helical assemblies 
(Chen et al., 2005), which seem to be dependent on the presence of DNA (Costa et 
al., 2008), reminiscent of the mechanism proposed for the bacterial initiator DnaA 
(Erzberger et al., 2006), involving a helical structure around which the initiator DNA 
can be wrapped.  
Role in fork elongation  
Although the function of MCM proteins as replicative helicases is generally 
accepted, how the helicase unwinds the DNA duplex is still an open question, with a 
number of different models being proposed. The steric-exclusion model represents 
the simpler mechanism (Enemark and Joshua-Tor, 2008), where a helicase ring 
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encircles a single DNA strand and translocates along it; the other strand is displaced 
by being excluded from the ring. This mechanism probably applies to the hexameric 
helicases belonging to the SF3 and SF4 families (Singleton et al., 2007), including 
the bacterial DnaB-like helicases, the bacteriophage T7 helicase (Singleton et al., 
2000) and the papillomavirus E1 helicase. The crystal structure of E1 bound to 
ssDNA and ADP strongly suggests a sequential mode of ATP hydrolysis linked to 
DNA translocation via the correlated movements of the PS1BH hairpins (Enemark 
and Joshua-Tor, 2006; Takahashi et al. 2005) have pointed out that in eukaryotes the 
helicase is loaded onto chromatin much before the helicase activity is actually 
needed (i.e. in the G1 rather than the S phase of the cell cycle). As presumably the 
loaded complex is topologically linked to DNA, the lack of evidence for origin 
melting before the beginning of S phase suggests that the complex is loaded onto 
dsDNA. However it cannot be ruled out that after initial loading onto dsDNA, MCM 
may undergo a rearrangement in such a way as to encircle ssDNA upon activation.  
The peculiarity of the initiation of DNA replication has therefore led to a number of 
different suggestions which are all linked by having a MCM complex encircling (or 
partially encircling) dsDNA. A scheme was derived from the proposed model for the 
SV40 LTag helicase. In contrast with the model proposed for the homologous 
papillomavirus E1, this protein was suggested to remain bound to the viral origin of 
replication as a double hexamer and melt the DNA by extruding ssDNA through 
lateral holes (Li et al., 2003), The last model proposed for MCM function advocates 
a hexameric helicase moving along dsDNA dragging a “ploughshare” that physically 
separates the two strands (Takahashi et al., 2005). The LTag mechanism can be 
classified in this category if the two rings that compose the double hexamer come 
apart.  
The available biochemical results are compatible with multiple models, showing that 
MCM complexes can displace a 59 nucleotides tail, translocate along dsDNA, or 
unwind a heterologous junction (Shin et al., 2003; Kaplan and O‟Donnell, 2004). 
MCM proteins can bind to both dsDNA and ssDNA (the latter with slightly higher 
affinity), but tend to have a higher affinity for forked and bubble substrates (Grainge 
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et al., 2003; You et al., 2003; De Felice et al., 2004). On the other hand the 
considerations summarized in Takahashi (2005) make a ploughshare model the most 
likely candidate to describe the activity of MCM proteins. Although the ploughshare 
could be an element of the MCM proteins or a separate protein (such as GINS or 
Cdc45), the fact that both archaeal and eukaryotic proteins display helicase activity 
in the absence of accessory factors argues in favor of an “internal” ploughshare 
(Figure 1.13).  
 
Figure 1.13 Mechanism of action of MCM proteins. A) schematic representation of a MCM protein 
and its loop B) Schematic diagrams illustrating the steric model, in wich the protein is moving on a 
ssDNA estruding the complementary strand, C) a diagram illustrating the ploughshare model with a 
strand of DNA coming out of the lateral hole and the second via the N-term region of the protein. 
Of the two loops that can be modelled to project into the channel (PS1BH and h2i), 
the strongest contender for the ploughshare is the helix-2 insertion. An alternative 
model is that the h2i loop works by translocating dsDNA inside the channel (with a 
mechanism similar to the PS1BH-mediated translocation of ssDNA in the E1 
helicase) and the “ploughshare” is simply represented by the lateral holes through 
which the ssDNA is extruded.  
A model in which one strand exits through a lateral hole while the other emerges 
through the N-terminal hexamer is consistent with biochemical data, showing that 
the NBH has an important role in the regulation of helicase activity (Barry et al., 
2009) and that the N-terminal domain has a marked preference for ssDNA (Liu et al., 
2008). Moreover the position, sequence conservation and mutagenesis of the EXT 
loops (Brewster et al., 2008; Brewster et al., 2010) support a role of the holes in 
helicase activity.  
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From EM single particle work (Costa et al., 2008), the lateral holes in MCM are 
often blocked by an isthmus of electron density that can be modelled by the inter-
subunit interaction between the PS1BH and ACL loop. This interaction is disrupted 
in the DNA-bound double hexamer structure, where presumably DNA binding has 
caused a re-orientation of the h2i and PS1BH towards the center of the channel, with 
the consequent disengagement of the PS1BH from the ACL, possibly providing a 
mechanism to “free” the hole for the exit of the ssDNA.  
Chapter 1 Introduction 
30 
 
1.3  The "new" eukaryotic MCM proteins. 
In the last few years two new eukaryotic proteins belonging to the MCM family have 
been identified and called MCM8 and MCM9 (Gozuacik et al., 2003; Johnson et al., 
2003; Lutzmann et al., 2005; Yoshida, 2005); these two proteins share a much higher 
homology to each other than to the other MCM2–7 proteins (Figure 1.14). Initially 
found only in higher eukaryotes, a more recent in-depth bioinformatics analysis 
demonstrates that these proteins are widely spread in all eukaryotic taxa, with 
random losses in some species. An interesting observation is that these two proteins 
seem to share an evolutional correlation, with both of them usually present or absent 
in the organisms analysed, possibly reflecting a functional correlation (Liu et al., 
2009).  
 
Figure 1.14 Schematic representation of the MCM family protein. The MCM8 and MCM9 
contain all the characteristics of the other MCM protein. But the last to share much homology between 
each other. (From Maiorano et al., 2006) 
An exception is represented by Drosophila: D. melanogaster Mcm8 (REC) protein is 
present despite the absence of Mcm9 and is highly divergent. The divergence of REC 
from other Mcm8 sequences may be related to the absence of Mcm9 and a radical 
change in the functional role. In fact, in addition to the role in DNA replication 
(Crevel et al., 2007), an implication in meiotic recombination has been identified for 
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REC. A model has been proposed in which REC drives crossover formation by 
acting at the repair synthesis step of meiotic recombination (Blanton et al., 2006). 
Drosophila was the only eukaryote analysed which has Mcm8 but lacks Mcm9 
suggesting, if the co-function and distinct co-ancestry hypothesis is correct, that REC 
may have assumed the function of both proteins or acquired a novel function that 
does not require Mcm9. 
Despite a few studies, the exact role of MCM8 in the cell is not clearly understood. 
This protein comprises a full set of the canonical motifs that have been shown to be 
essential for the helicase activity of the archaeal and/or eukaryotic MCM complexes. 
The protein does not associate with the MCM2-7 helicase complex. As reviewed in 
Maiorano et al. (2006) the information about the function of this protein are 
discordant. Studies carried out in human cells or in X. laevis egg extract demonstrate 
that this protein is interacting with chromatin after MCM3 during the S phase of the 
cell cycle. X. laevis MCM8 (xMCM8) colocalizes with RPA and in its absence the 
chromatin binding levels of RPA and Pol α-primase decrease. The recombinant 
xMCM8, produced in baculovirus-infected insect cells, shows helicase activity and 
ATPase activity stimulated by ssDNA; these results suggest that xMCM8 may act as 
a helicase during the elongation step. Other studies in human cell, however, suggest 
that human MCM8 (hMCM8) is needed for the recruitment of hCdc6 at the origin; 
hMCM8 results bound to the chromatin throughout the cell cycle and its 
downregulation by RNA interference leads to a delay in S phase entry and a lower 
level of hCdc6 bound to chromatin. 
Very little is known about MCM9, which is the largest MCM protein known to date, 
with a really sizeable 500 amino-acid C-terminal domain. This protein has a direct 
interaction with Cdt1 and is indispensable for its recruitment at the origin and for the 
formation of the pre-RC (Luztmann et al., 2008). 
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1.4  My project 
Archaeal C-terminal region: WH motif  
When I started my work the C-terminal region of MCM proteins was still structurally 
uncharacterized and the only information available was based on bioinformatics 
sequence alignments. To confirm the presence of a WH fold within the C-terminal 
region of MCM and provide an atomic model to define the biological role of this 
domain, I cloned, expressed and purified the C-terminal domains of MthMCM as 
well as SsoMCM, with the aim to carry out structural studies. The proteins have been 
obtained at high concentration and used for extensive crystallization experiments. In 
a parallel effort, preliminary NMR analysis has been performed in collaboration with 
Prof.ssa Henriette Molinari, Università di Verona. 
hMCM8 and hMCM9 
As demonstrated by biochemical studies the MCM8 proteins do not interact with the 
MCM2-7 helicase. This suggests that hMCM8 may act as a homo-oligomer and is 
therefore more similar to the archaeal model. I focused my work on this protein in 
order to get biochemical and structural information. As the full length MCM proteins 
have been rather resilient to large scale production and crystallization, I applied a 
different approach and separately express and purify a variety of sub-complexes 
corresponding to the different domains of the MCM8 (and possibly MCM9) 
complex. 
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2 Materials and Methods 
PfuTurbo DNA polymerase and PfuTurbo Buffer were obtained from Stratagene, 
restriction endonucleases, restriction Buffers, BSA for restriction digestions and T4 
ligase and T4 ligase Buffer were from New England Biolabs. IPTG (dioxan free) 
were from Carbosynth. Lysozyme (from chicken egg white), Maltose, PMSF, βΜE, 
BSA (for Western Blots) were all purchased from Sigma. Inhibitor cocktails EDTA 
free were purchased from Roche.  
All other Buffers, salts and reagents used for the preparation of solutions were 
purchased from Sigma  
2.1  Cloning of recombinant proteins in E. coli cells 
2.1.1 Expression vectors used for cloning. 
One commercially available bacterial expression vector and two other bacterial 
expression vectors kindly supplied by EMBL were used to produce the DNA 
constructs for the expression of recombinant proteins in E. coli. The main features of 
these vectors are summarized in Table 2.1.  
2.1.2 Primers 
The primers used for this work are listed in Table 2.2 and were provided by Sigma 
Genosys and resuspended in MilliQ water as manufacture datasheet indicates to 
reach a concentration of 100 µM. 
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Vector Promo 
ter 
Antibiotic 
resistance 
Tag Cleava 
ble with 
Size (bp) Restricti
on 
endonucl
ease used 
Supplier 
pProEX-
Hta 
Trc Ampicillin N-His 
(6H) 
TEV 4779 NcoI/XhoI 
for wHTH 
cloning 
BamHI/Xb
aI for 
hMCM8 
cloning 
Gibco-
BRL 
pETM 30 T7 Kanamycin 6H-GST TEV 6346 NcoI/XhoI 
for wHTH 
cloning 
EMBL 
pETM 41 T7 Kanamycin 6H-MBP TEV 5389 NcoI/NotI 
for 
hMCM8 
cloning 
EMBL 
pETSumo
/ 
CAT 
T7 Kanamycin 6H-Sumo Sumo 
protease 
6307 Restriction 
Free 
cloning 
Invitro 
gen 
Table 2.1 List of vector used for the cloning of wHTH , hMCM9 and hMCM8 construct. The 
vectors used and their characteristics: promoter, antibiotic resistance, fusion tag and protease to use, 
the size and their supplier. Finally the restriction enzymes that will be used for the cloning. 
2.1.3 Polymerase chain reaction (PCR). 
DNA sequences were amplified by PCR, following a standard PCR protocol which is 
described in Appendix 4 (Protocol A). The plasmid used as template in the PCR 
reaction are pET21-MthMCM kindly provided by Dr J.P. Gautier (, Schechter et al, 
2000), pET19-SsoMCM (Carpentieri et al., 2002) and pTrcHisC-hMCM8 provided 
by Dr. F.M. Pisani and a pTrcHisa-hMCM8 where the NcoI site has been eliminated 
by site-directed mutagenesis (see Section 2.1.5). For the amplification of plasmid 
PCR targets, the plasmid templates used in the PCR reactions were previously 
prepared using the QIAprep Spin Miniprep kit (Qiagen), according to the 
manufacturer‟s instructions.  
2.1.4 Preparation of DNA constructs  
The amplified PCR products were analysed by agarose gel electrophoresis (1% 
agarose in TBE Buffer) and 95 μl of the PCR reaction were purified using the 
QIAquick PCR purification kit (Qiagen) according to the manufacturer‟s instructions 
and eluted in 50 μl MilliQ water. 
Chapter 2 Materials and Methods 
35 
 
Name of primer Sequence (5' to 3') Restri 
ction site 
Gene 
name and 
species 
MthHTH NcoI AAATTTCCATGGGCGAGACAGGCAAG NcoI MthMCM 
MthHTH XhoI GGGTTTCTCGAGTCAGACTATCTT XhoI MthMCM 
SsoHTH NcoI AAATTTCCATGGGCACAATAATGACTG NcoI SsoMCM 
SsoHTH XhoI GGGTTTCTCGAGTCAGACTATCTTAAG XhoI SsoMCM 
SsoE605 NcoI GGGTTTCCATGGGCGAAAGTGGAAAAATA NcoI SsoMCM 
M1 BamH1 CCTCTGTCCCAAGCGGATCCGATGAATGGAG
AG 
BamH1 hMCM8 
S67 BamH1 ACCCCACAGGATCCGATGTCAACATTGGATC
G 
BamH1 hMCM8 
S373 BamH1 AGGACAGAAGGATCCGATGTCTGAGGATGGG
TG 
BamH1 hMCM8 
P203 BamH1 GGGTTTGGATCCGATGCCTTTGACACAGCTC BamH1 hMCM8 
G380 BamH1 GGGTTTGGATCCGATGGGAATGTTGATGGAG BamH1 hMCM8 
Q765 BamH1 GGGTTTGGATCCGATGCAGCATGGTTCTGGA BamH1 hMCM8 
End Xba GGTGAATCTAGATTACATAGTTTGAAGCTGG
TAAAC 
Xba hMCM8 
S372 Xba GGGTTTTCTAGAATCACTCTTTGTTTTCTGTC
C 
Xba hMCM8 
Q368 Xba GGGTTTTCTAGAATCCTGTCCTTTGCTATT Xba hMCM8 
S764 Xba GGGAAATCTAGAATCGGATCGCTCAAAATGT
AG 
Xba hMCM8 
MBPS67F GGGTTTCCATGGCATCAACATTGGATCG NcoI hMCM8 
MBPP203F GGGTTTCCATGGCACCTTTGACACAGCTC  NcoI hMCM8 
MPBS764 not GGGTTTGCGGCCGCATCGGACTGCTCAAAAT
CTAG  
NotI hMCM8 
MPBEnd not GGGTTTGCGGCCGCTTACATAGTTTGAAGCT
GGTA 
NotI hMCM8 
RFSumoM1 ATTGAGGCTCACAGAGAACAGATTGGT 
ATGAATAGCGATCAAGTTACACTG 
 hMCM9 
RFSumoL109 ATTGAGGCTCACAGAGAACAGATTGGTGGTC
TGGTGAGGGAACACATACCTAAAA 
 hMCM9 
RFSumoI278f ATTGAGGCTCACAGAGAACAGATTGGTATCA
TCATGGATGAGGAGGTCCAA 
 hMCM9 
RFSumoQ627 TTTGCGCCGAATAAATACCTAAGCTTGTCTTT
ACTGCTCTCCAGGGTTTTCAGGAA 
 hMCM9 
RFSumoP665 TTTGCGCCGAATAAATACCTAAGCTTGTCTTT
ATGGTTGGGATTGGTGCACACTCTG 
 hMCM9 
RFSumoI278r TTTGCGCCGAATAAATACCTAAGCTTGTCTTT
AGATCCCTGGGGACTGCTCATTATT 
 hMCM9 
Table 2.2 List of primer used for the cloning. The sequences underlined correspond to the 
restriction site sequence, whereas the red sequences of hMCM9 correspond to the complementary 
sequence of the pETSumo plasmid that will be used for the cloning using a Restriction Free (RF) 
cloning technique. 
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Restriction endonuclease digestion of DNA  
All restriction endonuclease digestions were performed using restriction enzymes, 
Buffers and BSA (required for some digestions, according to the manufacturer‟s 
instructions) from New England Biolabs.  
Newly synthesized PCR products were digested with their respective restriction 
enzymes, in order to produce DNA fragments (insert DNA) to be used in subsequent 
ligation reactions. Typically, 48 μl of the purified PCR products were used for 
restriction endonuclease digestion. The reaction contained 3 μl of restriction enzyme 
for single digestions (one enzyme) and 2 μl of each restriction enzyme for double 
digestions (two different enzymes), 10x Buffer and BSA when required. Deionised 
water was added to a final volume of 60-70 μl and the reaction was incubated for 3 
hr at 37ºC.  
Restriction digestion of existing plasmids was performed to produce either vector (V) 
or insert (I) DNA fragments to be used in subsequent ligations. Typically, 8-10 μg of 
plasmid DNA were used for each digestion, in a total volume of 50-60 μl for single 
restriction enzyme digestions and 60-70 μl for double digestions. The reaction 
contained 4 μl of restriction enzyme for single digestions and 2.5 μl of each 
restriction enzyme for double digestions, 10x Buffer and BSA when required. The 
reaction was incubated for 2½ hr at 37ºC. All digested DNA fragments were 
subjected to agarose gel electrophoresis (1% agarose in TBE Buffer) and purified 
from agarose slices using the QIAquick Gel extraction kit (Qiagen), according to the 
manufacturer‟s protocol. The purified DNA fragments were eluted in 40 μl 
BufferMilliQ water. 
Ligation of plasmid vector and insert DNA  
Ligation reactions for DNA to be inserted into plasmid vectors were performed using 
T4 DNA ligase (NEB), according to the manufacturer‟s protocol. The amount of 
total DNA (insert and vector) used for each ligation reaction was 160-200 ng. The 
molar ratio of vector to insert DNA was typically 1:5 and the final reaction volume 
was 10 μl, including 1 μl T4 DNA ligase (NEB). The ligation reaction mixture was 
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incubated for overnight at 16°C and then either used directly for the transformation 
of competent cells or stored at -20ºC. 
Transformation of bacteria with plasmid DNA 
E. coli DH5α chemically competent cells (Stratagene), prepared according to 
protocol B (Appendix 4) were used for maintaining the plasmids. For the 
transformation, 1 µL of DNA plasmid at ~25 ng/µL was added to a 25 µL aliquot of 
DH5α cells. The mixtures were incubated on ice for 30 minutes, heat shocked at 
42°C for 45 seconds and incubated on ice for 2 additional minutes. LB (Luria 
Bertani) medium, preheated to 42°C, was added to the mixture tubes to a final 
volume of 250 µL. The transformation reactions were then incubated for 1 hour at 
37°C, shacking at 225-250 rpm. A volume of 100 µL of each reaction was streaked 
on LB agar plates containing either kanamycin or ampicillin depending on the 
resistance gene carried by the vector, at a final concentration of 50µg/µL and 100 
µg/µL, respectively. 
Preparation of plasmid minipreps 
Single colonies from agar plates were inoculated into 5 mL LB broth medium 
supplemented with the appropriate antibiotics and the cultures grown for 16 hours at 
37°C with shaking at ~225 rpm. The cells were pelleted by centrifugation at 3,500 g 
for 15 minutes at 4°C. Plasmid DNA was purified from cell pellets using the 
QIAprep Spin Miniprep kit (Qiagen), according to the manufacturer‟s protocol, 
eluted with 30 µL of MilliQ H2O (Qiagen) and stored at -20°C. The typical yield of 
plasmid DNA was ~100 ng/µL, as checked spectrophotometrically by measuring the 
absorbance at a wavelength of 260 nm (Table 2.3). 
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Construct name Vector Enzyme used Sequenced  
MthWH pProExHta NcoI/XhoI Yes 
SsoWH pProExHta NcoI/XhoI Yes 
SsoE605 pProExHta NcoI/XhoI Yes 
MthGSTWH pETM 30 NcoI/XhoI Yes 
SsoGSTWH pETM 30 NcoI/XhoI Yes 
hMCM8_1 pProExHta BamH1/Xba1 Yes 
hMCM8_2 pProExHta BamH1/Xba1 Yes 
hMCM8_3 pProExHta BamH1/Xba1 No 
hMCM8_4 pProExHta BamH1/Xba1 No 
hMCM8_5 pProExHta BamH1/Xba1 Yes 
hMCM8_6 pProExHta BamH1/Xba1 Yes 
hMCM8_7 pProExHta BamH1/Xba1 Yes 
hMCM8_8 pProExHta BamH1/Xba1 Yes 
hMCM8_9 pProExHta BamH1/Xba1 Yes 
hMCM8_10 pProExHta BamH1/Xba1 Yes 
hMCM8_11 pProExHta BamH1/Xba1 Yes 
hMCM8_12 pProExHta BamH1/Xba1 Yes 
hMCM8_13 pProExHta BamH1/Xba1 Yes 
hMCM8_14 pProExHta BamH1/Xba1 Yes 
hMCM8_15 pProExHta BamH1/Xba1 Yes 
hMCM8_16 pProExHta BamH1/Xba1 Yes 
hMCM8_17 pProExHta BamH1/Xba1 Yes 
MBPhMCM8_7 pETM41 NcoI/NotI No 
MBPhMCM8_8 pETM41 NcoI/NotI Yes 
MBPhMCM8_11 pETM41 NcoI/NotI Yes 
MBPhMCM8_12 pETM41 NcoI/NotI Yes 
Table 2.3 List of constructs used for this work. Here are listed the constructs produced, the vector 
where have been insert and with enzymes have been used for the cloning. 
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2.1.5 Site-directed mutagenesis  
Site-directed mutagenesis was used to mutate the R87 in Ala, Glu or Leu, and to 
mutate S342 and K344 in two Ala residues in MthMCM; a silent point-mutation is 
performed in hMCM8 to remove a NcoI cutting site in position 1597 on the clone. 
All reactions were performed with the QuickChange XL Site-Directed Mutagenesis 
Kit (Stratagene), following the manufacturer‟s instructions. The method utilises 
double-stranded plasmid DNA as a template, and a pair of complementary 
oligonucleotide primers, incorporating the desired mutation. The template plasmid 
DNA, as well as the primer pair used for the construction of each mutant expression 
vector are listed in Table 2.4. 
Name of mutant Template 
DNA 
plasmid 
Primer F (5'→3) Primer R (5'→3') 
MthMCM 
R87A 
pET21-
MthMCM 
R87Af 
GTGGACCTCAACATAGCGTT
CAGCGGGATCAG 
R87Ar 
CTGATCCCGCTGAACGCTAT
GTTGAGGTCCAC 
MthMCMR87E pET21-
MthMCM 
R87Ef 
GAATGTGGACCTCAACATAG
AATTCAGCGGGATCAGCAAC 
R87Er 
GTTGCTGATCCCGCTGAATTC
TATGTTGAGGTCCACATTC 
MthMCMR87L pET21-
MthMCM 
R87Lf 
GTGGACCTCAACATACTGTT
CAGCGGGATCAG 
R87Lr 
CTGATCCCGCTGAACAGTAT
GTTGAGGTCCAC 
MthMCMS342A pET21-
MthMCM 
S342Af 
CAGGGGGATATACACCGCCG
GTAAGGGTACCTCAG 
S342Ar 
CTGAGGTACCCTTACCGGCG
GTGTATATCCCCCTG 
MthMCMK344A pET21-
MthMCM 
K344Af 
GATATACACCAGCGGTGCAG
GTACCTCAGGGGTC 
K344Ar 
GACCCCTGAGGTACCTGCAC
CGCTGGTGTATATC 
MthMCMS342A/
K344A 
pET21-
MthMCMS
342A 
S342AK344Af 
CAGGGGGATATACACCGCCG
GTGCAGGTACCTCAG 
S342AK344Ar 
CTGAGGTACCTGCACCGGCG
GTGTATATCCCCCTG 
pTrcHisA-
hMCM8 no NcoI 
pTrcHisA-
hMCM8 
hMCM8 PM F 
GCCTTGTTGGAAGCTATGGA
GCAGCAAAG 
hMCM8 PM r 
CTTTGCTGCTCCATAGCTTCC
AACAAGGC 
Table 2.4 List of the primers used for the Quickchange system. In red are showed the mutations 
introduced.  
Mutated constructs were generated using a modified PCR reaction protocol, which is 
detailed in Appendix 4 (Protocol C). Following temperature cycling, the reactions 
were digested with 1 μl of the DpnI restriction enzyme at 37ºC, for 1.5 hr, so as to 
digest the methylated parental DNA. A 4 μl aliquot from the reaction mixture was 
then used to transform 45 μl DH5α competent cells (Stratagene) and the cell mixture 
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was streaked on LB agar plates, containing ampicillin. After overnight incubation at 
37ºC, preparation of plasmid DNA from isolated colonies proceeded as previously. 
Mutant DNA constructs were sequenced (BMR Genomics, Padova) to confirm the 
introduction of the correctly mutated bases. For the double mutant a second PCR is 
performed with a second couple of primer. 
2.1.6 RT PCR 
The production of the cDNA of hMCM9 was performed using the M-MLV Reverse 
Transcriptase (Invitrogen). The total RNA of different proliferating cell line (Table 
5) was used and the first strand (FS) reaction synthesis was processed with a d(T)16 
as recommended by the producer of the Transcriptase (see appendix 4, protocol E). 
The second strand synthesis consisted of a PCR reaction (see section 2.1.3) using FS 
as template and carried out with the primers listed in Table 2.5. 
Cell line Tissue 
MCF10A Mammary gland  
HepG2 Liver hepatocellular carcinoma 
HeLa Cervical cancer 
A549 Lung adenocarcinoma 
SK-N-AS Neuroblastoma 
Table 2.5 List of the cell line used in this work. 
2.1.7 Restriction Free Cloning 
Restriction Free (RF) cloning methodology is part of the Ligation Independent 
Cloning (LIC) processes which, were developed for the directional cloning of PCR 
products without restriction enzyme digestion or ligation reactions. The RF 
procedure is a universal cloning method allowing a precise insert of a DNA fragment 
into any desired position within a circular plasmid. The RF cloning is a twosteps 
process (Figure 2.1). Initially, the gene of interest is amplified along with primers 
containing complimentary sequences (25-30 bp) to the flanking sites of integration in 
the target vector. The two strands of the PCR product obtained in the first stage are 
used as mega primers for the second stage of amplification. In the second stage the 
PCR product and the target vector are mixed and following amplification reaction the 
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gene of interest is integrated into the circular vector to a pre-defined positionThe first 
PRC step is performed as described in Appendix 4 (protocol A). The PCR are 
cleaned using the Qiaquick PCR purification kit (Qiagen) as manufacture suggests 
and the DNA eluted in 40 µl of deionised water. 
This DNA will be used as megaprimer for the RF PCR (Appendix 4, protocol F), 
which is a linear amplification and the 10 µl of product digested with Dpn1. These 
are then used to transform 90 µl of DH5α. 
 
 
Figure 2.1 Schematic representation of the restriction-free (RF) cloning (from van den Ent F 
2006,) 
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2.2 Protein preparation  
2.2.1 MthMCM and mutants expression and purification. 
A construct containing the wt MthMCM gene cloned into a pET21b (Novagen) 
expression vector (a gift from J.P. Gautier, Columbia University) was used to 
produce the full-length protein with a non-cleavable C-terminal His-tag. A construct 
containing a MthMCM gene lacking subdomain A cloned into a pET21a expression 
vector  (a gift of Zvi Kelman, University of Maryland), was used to produce a 
C-terminal His-tagged protein missing residues 1-91. All the site-direct mutants 
constructs were obtained as described previously.  
Protein expression 
Transformation of BL 21 strain of E  coli cells was performed using 1 μl of plasmid 
miniprep added to a 25 μl aliquot of competent cells. The transformation proceeded 
following a protocol similar to that outlined in Paragraph 2.1.4, and cells were plated 
on LB agar plates containing ampicillin. Few colonies of transformed E. coli 
competent cells were grown at 37ºC overnight in 80 ml of LB medium containing 
ampicillin. The overnight culture was used to inoculate a 20-fold volume of fresh LB 
medium supplemented with ampicillin (i.e. 40 ml per litre, for a total of 4 liters). The 
culture was grown at 37ºC with shaking at 225 rpm until an OD600 of approximately 
0.8 was reached, at which point protein expression was induced with 0.5 mM IPTG 
and cells were grown for an additional 4 hours. Cells were harvested by 
centrifugation and the pellet was stored at -80ºC. 
Purification consisted of nickel-affinity, followed by heparin-affinity 
chromatography and gel filtration chromatography. All protein purification steps 
were carried out at 4ºC, using an ÄKTA Fast Protein Liquid Chromatography 
(FPLC) apparatus (GE Healthcare). The data were collected using the Unicorn Data 
system (ÄKTA FPLC) and edited using Microsoft Excel. 
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Protein extraction 
Each cell pellet was thawed and re-suspended in 30 ml of re-suspending Buffer (20 
mM Tris-HCl pH 7.9, 500 mM NaCl, 10 mM imidazole, 10% glycerol) 
supplemented with 1 mg/ml lysozyme and 1 mM AEBSF protease inhibitor. The 
suspension was incubated at 4°C under magnetic stirring for 30 min to allow the 
lysozyme to act, followed by sonication on ice. Twenty 15 sec pulses with 45 sec in 
ice between each pulse were performed at 40% amplitude (Soniprep 150). The cell 
lysate was clarified by centrifugation for 45 min at 26,000 g and the supernatant was 
filtered through a 0.22 μm filter before applying to affinity columns. 
Protein purification 
For the purification of MthMCM and its mutants, a HiTrap chelating column (5 ml 
column volume (CV), GE Healthcare) was used. The column was charged with Ni
2+
 
ions by 4 CV of 0.1 M NiSO4 (charge solution), washed with 3 CV deionised water 
and subsequently equilibrated with 5 CV of Nickel Buffer A (20 mM Tris-HCl pH 
7.9, 500 mM NaCl, 10 mM imidazole, 10% glycerol). The filtrate was then loaded on 
the column, followed by an extensive wash with Nickel Buffer. The column was 
washed with 3 CV of 50 mM imidazole in Nickel Buffer and then a linear gradient 
from 50 mM to 500 mM imidazole was applied to elute the protein of interest. 
Fractions containing the target protein product, as assessed by SDS-PAGE, were 
pooled and dialysed overnight in Heparin Buffer A (20 mM Hepes, 50 mM NaCl, 
10% glycerol). The dialysed sample was loaded onto a Heparin HiTrap column (5 ml 
GE Healthcare) equilibrated in Heparin Buffer. The bound protein was eluted with a 
3 CV linear gradient from 50 mM to 1 M NaCl in the same Buffer. This step was 
critical in removing contaminating DNA. The fractions containing the protein were 
pooled and concentrated on Amicon Ultra 15 (Millipore) centrifugating the tubes as 
recommended by the producer. The sample was then spun down and filtered to 
remove any precipitate and loaded on a Tricorn Superose 6 10/30 gel-filtration 
column (GE Healthcare) in a Buffer composed by 30 mM Hepes pH 7.5, 150 mM 
NaCl (GF Buffer A). Fractions corresponding to the size of a double ring were 
collected. 
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2.2.2 Archaeal C-terminal Winged Helix (WH) expression and 
purification. 
Protein expression 
As for the MthMCM, also WH construct were transformed in BL 21 E. coli cell 
using 1.5 µl of the appropriate plasmid (pProExHta-MthWH, pPRoExHta-SsoWH, 
pProExHta-SsoE605). The transformation proceeded following a protocol similar to 
that outlined in Paragraph 2.1.4, and cells were plated on LB agar plates containing 
ampicillin. Few colonies of transformed E. coli competent cells were grown at 37ºC 
overnight in 80 ml of LB medium containing ampicillin. The overnight culture was 
used to inoculate a 20-fold volume of fresh TB medium supplemented with 
ampicillin (i.e. 40 ml per litre, for a total of 6 liters). The culture was grown at 37ºC 
with shaking at 225 rpm until an OD600 of approximately 1 was reached, at which 
point protein expression was induced with 1 mM IPTG and cells were grown for an 
additional 5 hours. Cells were harvested by centrifugation and the pellet was stored 
at -80ºC. 
Protein purification 
The protein extraction was performed as already described for the MthMCM protein, 
as well as the first step of the purification using a 5ml HiTrap chelating column 
charged with Ni
2+ 
ions. Fractions containing the target protein product, as assessed 
by Tris-Tricine SDS-PAGE, were pooled and dialysed overnight in TEV cleavage 
Buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 0.5 mM EDTA and 10% glycerol). 
His-tagged rTEV protease was produced as described in Protocol D (Appendix 4) 
and added to the dialysed protein (a total of 1 mg of TEV protease for ~50 mg of 
His-tagged protein) kept in a reducing environment by βME at 2 mM. The 
endoprotease digestion was typically carried out overnight at 4ºC. The digested  
sample was loaded onto the Ni
2+ 
column to remove the His-tagged TEV and any 
trace of uncleaved target protein (TEV cleanup step), after that the sample was 
concentrated and further purified using size-exclusion chromatography with a 
HiLoad Superdex-75 16/60 gel-filtration column (GE Healthcare). Prior to use, the 
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column was pre-equilibrated with ≥2 CV of GF Buffer A (30mM Hepes pH 7.5, 150 
mM NaCl) or in a NMR filtration Buffer (30 mM phosphate Buffer pH 6.5, 150 mM 
NaCl) according to the manufacturer‟s instructions. Each run was performed at a 
flow rate of 0.5 ml/min, and a 5ml loop was used to inject the sample onto the 
column. Sample were typically purified by isocratic elution with 1 CV (~125 ml) of 
gel-filtration Buffer. During elution, 0.5 ml fractions were collected and assessed by 
Tris-Tricine SDS-PAGE for protein purity and concentration. The protein were then 
concentrated to be treated as described in section 2.6. 
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2.2.3 hMCM8 protein expression and purification 
Small-scale expression and solubility assays  
Before attempting large-scale expression of any newly synthesized DNA construct 
the expression of the target protein was verified by the analysis of whole-cell 
extracts, as described below. Once expression of the target protein was verified, 
determination of the protein solubility and optimization of growth conditions were 
carried out using the small-scale batch purification procedure described in the 
following Section.  
Analysis of whole cell extracts and Small-scale batch purification  
Single colonies of E. coli cells harbouring the plasmid(s) being tested were used to 
inoculate 10ml of LB or TB media (containing appropriate antibiotics), in 50 ml 
tubes to allow a sufficient aeration during growth. Different bacterial strains were 
used for the test (Table 2.6) to increase the chances of success. 
E. coli (DE3)  
Strain name 
Resistence Provider 
BL 21  Stratagene 
BL 21 codon+ RIP chloramphenicol Stratagene 
Bl 21 codon + RIPL chloramphenicol Stratagene 
BL 21 Gold  Stratagene 
BL 21 Star  Invitrogen 
Rosetta 2 chloramphenicol Novagen 
B 834  Novagen 
Table 2.6 E. coli (DE3) strain tested. The strain cell used for the small scale expression and their 
antibiotic resistence. 
The cultures were grown at 37ºC, shaking at 225 rpm until reaching an optical 
density of 0.6-0.7 at 600 nm for the cells in LB broth, or 2-2.5 OD for those in TB 
broth. Protein expression was induced by addition of IPTG at different concentration 
ranging from 0.1 to 1 mM, at different temperature and times (37°C for 5 hours,  
25°C overnight/24 hours, 18°C for 48 hours). Autoinduction media were also tested 
at 25°C for 24 hours. Aliquots were removed from the culture prior to addition of 
Chapter 2 Materials and Methods 
47 
 
IPTG (pre-induction sample) and prior to harvesting (post-induction sample). The 
aliquots were pelleted by centrifugation at 16,000 g for 2 min at 4ºC, the supernatant 
was removed and each cell pellet was resuspended in 20 μl 2x SDS Sample Buffer 
and heated at 95ºC for 10 min to fully lyse the cells and denature the proteins. The 
pre-induced and post-induced SDS-whole cell lysates were analysed by denaturing 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE, Section 2.12.3), followed by 
Instant blue staining to verify expression of the target recombinant proteins by 
comparing the pre- and post-induction whole-cell extracts from each culture.  
Cell pellets were thawed on ice and resuspended in 1 ml BufferNickel Buffer A: 20 
mM Tris-HCl pH 7.9, 500 mM NaCl, 10 mM imidazole, 10% glycerol, 
supplemented with 1 mg/ml lysozyme and 1 mM PMSF protease inhibitor and the 
suspension was incubated on ice for 30 min. Cell lysis was performed by 3-4 cycles 
of freeze (-80°C) and thawed (+37°C). The lysates were centrifuged for 30 min at 
26,000 g to remove cellular debris and the supernatant (soluble fraction) was 
transferred to a fresh 1.5 ml microcentrifuge tube.  
Ni-NTA fastflow resin (Qiagen) was used for the analysis of His-tagged target 
proteins. The resins were prepared according to the manufacturers‟ instructions as 
50% slurries Nickel Buffer A prior to use. A 50 μl aliquot of resin was added to the 
supernatant and the tube was incubated with gentle rotation at 4°C for 45 min. The 
suspension was centrifuged at 500 g for 5 min to sediment the resin. The supernatant 
was removed and the resin was washed with 1 ml Buffer by resuspending with a 
pipette, centrifuging and discarding the supernatant, for a total of three washes. The 
third wash was performed with Nickel Buffer A supplemented with 50 mM 
imidazole, to reduce unspecific binding of proteins to the resin. 25 μl of 2x SDS 
Sample Buffer were added to the sedimented resin and the suspension was heated at 
95ºC for 10 min to elute the bound proteins from the resin. The sample was 
centrifuged at 16,000 g for 1 minute and 15-20 μl of the resin was analysed by SDS-
PAGE with Instant blue staining. 
Once the optimal condition for the each construct were found, large scale expression 
experiments (i.e. 6 liters culture) were performed. 
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Protein extraction 
The cell pellet from 1 L of culture was thawed and resuspended in 20 mL (for cells 
grown in LB) or 40 mL (for cells grown in TB) of affinity binding Buffer (MBP 
Buffer or Nickel Buffer depending on the protein to be purified), supplemented with 
1 mg/mL of lysozyme (Sigma) and 2 mM of the protease inhibitor AEBSF (4-(2-
aminoethyl) benzenesulfonyl fluoride, Sigma). The resuspended solution was 
incubated on ice for 20 minutes, stirring with a magnetic bar, in order to allow the 
lysozyme to act. The suspension was then sonicated on ice with 30 short pulses of 15 
seconds each, at 40% amplitude (Soniprep 150). The cell lysates were clarified by 
centrifugation for 45 minutes at 26,000 g and the supernatant filtered through a 0.22 
mm cut-off filter before applying to affinity columns. 
Purification of MBP-tagged proteins 
The protein expressed as fusion with Maltose-binding protein (MBP) were subjected 
to a first purification step using a MBPtrap column (GE Healthcare, with a volume of 
1 or 5 ml, depending on the volume of culture). After a rinse in deionised water the 
column was pre-equilibrated in MBP Buffer (30 mM Tris pH 7.4, 300 mM NaCl, 5% 
Glycerol, 1 mM EDTA). The clarified cell extract was loaded onto the column and 
the unbound proteins were washed out with MBP Buffer until the UV baseline was 
reached. The elution of the protein of interest was carried out with 5 CV of MBP 
Buffer containing 10 mM Maltose. Then the protein was concentrated and injected 
onto a size exclusion column (GE Healthcare, Tricorn Superose 6 10/30) using 200 
or 500 µl loop. The Buffer used contains 30 mM Hepes pH 7.5, 150 mM NaCl. 
Purification of His-tagged proteins 
For all the expressed proteins that possessed a hexa-histidine tag, the first 
purification step was metal-affinity chromatography using a HiTrap Chelating FF 
crude column (with a volume of 1ml or 5 mL depending on the volume of culture, 
GE Healthcare). The column was washed with deionised filtered water, charged with 
ions by 0.1 mM NiSO4 or CoSO4 and then processed as already described prior to 
equilibration with 5 CV of Nickel Buffer (20 mM Tris-HCl, pH 7.9, 0.5 M NaCl, 
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10% glycerol). The clarified cell extract was then loaded onto the column and the 
unbound protein washed with Nickel Buffer until a stable UV baseline was recorded. 
The column was washed with a Nickel Buffer containing 10 mM ATP/MgCl2 to 
remove contamination by GroEL, and a second washing step with high salt 
concentration (1 M) was added to remove nucleic acid contamination. The column 
was then washed with 50 mM imidazole to remove proteins that bound non-
specifically. The His-tagged protein was finally eluted by applying a linear gradient 
from 50 mM to 500 mM imidazole in Nickel Buffer. The eluted fractions were 
collected and their content analysed on a SDS-PAGE gel and visualised using Instant 
Blue stain (Biosense). 
For the hMCM8_2 construct the second purification step consisted in a Heparin 
HiTrap column (5 ml, GE Healthcare), equilibrated in Heparin Buffer C (50 mM Tris 
pH 7.4, 500 mM NaCl, 10% Glycerol). The elution of the protein was carried out 
applying a linear gradient of NaCl, from 500 mM to 2 M. 
A purification step involving size-exclusion chromatography was used for the 
hMCM8_14 construct using a HiLoad Superdex 200 (~120 mL CV, GE Healthcare) 
gel-filtration column. The column was washed with 2 CV of deionised water and 
then equilibrated with 2 CV of the appropriate size exclusion chromatography Buffer 
(30 mM Hepes pH 7.5, 300 mM NaCl, 10% Glycerol; GF Buffer B). Proteins were 
concentrated at 4°C, using the appropriated molecular weight cut-off concentrators 
(Millipore) according to the manufacturer‟s instructions, and injected onto the 
column using a 5 mL loop. The samples were purified by 1.5 CV isocratic elution 
and the 0.5 mL fractions assessed by SDS-PAGE. 
2.3 SDS-PAGE 
2.3.1 Tris-Glycine-SDS 
Protein samples were analysed by electrophoresis under denaturing, reducing 
conditions using discontinuous SDS-polyacrylamide gels (4% for the stacking gel 
and a range between 8-15% for the separating gel, depending on the protein of 
interest). Samples were prepared by addition of 2x SDS sample Buffer and heating at 
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95ºC for 5 min. Electrophoresis was carried out at a constant voltage (200V) for 45-
55 min in 1x Tris-glycine-SDS Buffer. Gels were stained with Instant blue 
(Biosense) for visualisation. 
2.3.2 Tris-Tricine-SDS 
Small protein samples were analysed by electrophoresis using discontinuous SDS-
polyacrylamide gel (4% in 0.75 M Tris pH 8.5 fo the stacking and 16% in 1M Tris, 
pH 8.5 for the separating). The samples was prepared as described above and 
electrophoresis was carried out at a constant voltage (150V) for 50 min using 1X 
Cathode Buffer and 1X Anode Buffer (recipe Appendix 3). Gels were either stained 
with Instant blue (Biosense) for visualisation. 
2.4 Determination of theoretical protein parameters 
Theoretical values for the isoelectric point (pI), molecular weight (MW) and 
extinction coefficient at 280 nm of the different proteins used in this study were 
calculated using the Protparam tool at the Expasy Server: 
http://www.expasy.ch/tools/protparam.html. 
2.5 Determination of protein concentration 
Protein concentrations were determined spectrophotometrically by measuring the UV 
absorbance at a wavelength of 280 nm (NanoDrop Spectrophotometer, Thermo 
Scientific) and applying the Lambert-Beer law with the theoretical extinction 
coefficient calculated as indicated above. 
2.6 Protein crystallization 
2.6.1 Crystallization screening 
Crystallization trials were carried out using the sitting drop vapour-diffusion method. 
Peak fractions from the gel-filtration purification step were pooled and concentrated 
using 10 kDa molecular weight cut-off concentrators (Amicon 15 Ultra Millipore) to 
a final protein concentration of 10 to 90 mg/ml (depending on the protein solubility). 
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The sample was filtered through a 0.22 μm microcentrifuge filter (Centrisart-C4, 
Sartorius) and immediately used for crystallisation using the Mosquito liquid 
handling robot (TTP LabTech‟s). Crystallisation drops (sitting drop) contained either 
1:1 or 2:1 volume ratios of protein to reservoir respectively, with final drop volume 
of 200 or 300 nL. Initial crystallisation trials were set up at room temperature, at 4°C 
or 37°C using commercially available screens: Hampton Crystal Screen 1 and 2, 
Hampton PEG/Ion and Natrix, Index Screen, SaltRX (all from Hampton Research), 
Wizard 1, 2 (Emerald Biosystems), Classic, Classic II, pH clear, pH clear II, 
comPAS, PACT and JCSG+ (Qiagen).  
2.6.2 Optimization 
Optimisation of the crystallisation conditions involves the manipulation of the 
crystallisation phase diagram with the aim of leading crystal growth in the direction 
that will produce the desired results. Crystal growth can also be controlled by 
separating the processes of nucleation and growth. This can be achieved by 
bypassing the nucleation zone by inserting crystals, crystal seeds or other nucleants 
directly into the metastable zone. 
 
Figure 2.2 A schematic phase diagram for a protein crystallization experiment 
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At high protein and high precipitant concentrations, precipitation occurs as shown. 
At low protein and low precipitant concentration, the solution remains clear. Near the 
bottom of the precipitation zone, there is an area where protein crystal nuclei form 
and grow (red curve, Figure 2.2). Below this is an area often called the metastable 
zone where crystals will grow, but no nucleation occurs. A preformed crystal (e.g. 
from the nucleation zone, or from other screening) placed into this area it will grow.  
If the nucleation zone is small, crystallization may be a rare event. By adding seeds 
to the experiments, crystals can grow in experiments that never leave the metastable 
zone. The crystal transfer can be performed with different technique.  
To optimse crystal growth and morphology I used the following: 
Streak-seeding or touch-seeding: a natural fiber is used to touch a crystal and transfer 
crystal particles in a 2 µl drop containing a 1:1 ratio protein/reservoir.  
Micro-seeding: a crystal is smashed and the microcrystals are transferred by manual 
pipetting, upon serial dilutions. 
In both technique the microcrystals are transferred in the same reservoir that gave 
positive results, but scaling up the final volume of the reaction. 
Cross-seeding: a crystal is smashed and the diluted microcrystal are used in 96 well 
screening. The drops are obtained in the same way described for the preliminary 
screening, but using a ratio of crystal-solution/protein/reservoir of 1:2:1. 
2.7 Protein biochemical assays  
Preparation of radiolabelled oligonucleotides 
DNA oligonucleotides were used for the nucleic acid binding assays; sequences of 
all the probes tested are listed in Table 2.7. DNA oligonucleotides were purchased 
from sigma Genosys. DNA fork was obtained by putting a poly(dT) tail at 
complementary ends of each oligonucleotides.. For the radiolabelling reaction, 1 μl 
of the probe at 10 μM concentration was mixed with 1.5 μl [γ32P]ATP (10 μCi/μL, 
3000 Ci/mmol, Perkin Elmer), 1 μl T4 Polynucleotide Kinase (PNK, Roche), 2 μl 
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10× T4 PNK Buffer and RNase-free deionised water to a final volume of 20 μl. The 
mixture was incubated for 1 hour at 37°C. The radiolabelled oligonucleotides were 
then purified using BioSpin 6 desalting columns (Biorad) according to the 
manufacturer‟s protocol and eluted in Tris-HCl Buffer pH 8.0. To prepare the double 
stranded substrates, the labelled oligonucleotide was mixed with a 2 fold molar (for 
dsDNA) or 3 molar fold (for ForkDNA) excess of the cold complementary strand in 
presence of 0.3M NaCl before passing through the desalting column. 
Name of 
primer 
Sequence (5' to 3') Final 
concentration  
41mer f AATCATAGATAGTATCTCCGTGCAAGATAATCACGA
GTATC* 
0.1 μM 
41mer r GATACTCGTGATTATCTTGCACGGAGATACTATCTA
TGATT 
0.1 μM 
61 mer Fork f AATCATAGATAGTATCTCCGTGCAAGATAATCACGA
GTATCTTTTTTTTTTTTTTTTTTTT* 
0.1 μM 
61 mer Fork r TTTTTTTTTTTTTTTTTTTTGATACTCGTGATTATCTT
GCACGGAGATACTATCTATGATT 
0.1 μM 
Table 2.7 Rabiolabeled oligonucleotides. List of the oligonucleotides used for the biochemical 
assays, alone or in combination, so as to obtain dsDNA and Fork substrates. * indicates the strand 
labeled with 32P γ-ATP.  
2.7.1 Electrophoretic mobility shift assays (EMSA) 
MthMCM proteins 
Complexes formed between the proteins and DNA were detected by a gel mobility 
shift assay in reaction mixtures (10 µl) containing 25 mM Hepes-NaOH (pH 7.5), 50 
mM Na acetate, 10 mM MgCl2, 1 mM ATP, 1 mM dithiothreitol, 100 µg/ml bovine 
serum albumin, 50 fmol labeled oligonucleotide, indicated amount of pmol of 
proteins (as monomers). After incubation at 60 °C for 10 min, 5 µl of 5X loading 
Buffer (0.1% xylene cyanol, 0.1% bromphenol blue, 50% glycerol) was added to 
stop the reaction. Aliquots of the reaction mixture were electrophoresed for 1.5 h at 
100V through a 4% polyacrylamide gel containing 6 mM magnesium acetate and 5% 
glycerol in 0.5X TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA). 
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hMCM8 
Complexes formed between the proteins and DNA were detected by a gel mobility 
shift assay in reaction mixtures (10 µl) containing 25 mM Hepes-NaOH (pH 7.5), 25 
mM Na acetate, 10 mM Mg acetate, 1 mM dithiothreitol, 100 µg/ml bovine serum 
albumin, 50 fmol labeled oligonucleotide and increasing amount of protein. The 
DNA binding is also tested in presence of nucleotides (ATP). After incubation at 
37 °C or 25 °C for 60 min, 5 µl of 5X loading Buffer (0.1% xylene cyanol, 0.1% 
bromphenol blue, 50% glycerol) was added to stop the reaction. Aliquots of the 
reaction mixture were electrophoresed for 1.5 h at 100V through a 4% 
polyacrylamide gel containing 6 mM magnesium acetate and 5% glycerol in 0.5X 
TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA). 
2.7.2 Helicase assay 
MthMCM proteins 
DNA helicase activity was measured in reaction mixtures (10 µl) containing 20 mM 
Tris-HCl (pH 8.5), 10 mM MgCl2, 2 mM dithiothreitol, 100 µg/ml bovine serum 
albumin, 5 mM ATP, 10 fmol of labeled DNA substrate, and the various MCM 
mutant proteins. After incubation at 60 °C for 1 h, reactions were stopped by adding 
5µl of 5X loading Buffer (100 mM EDTA, 1% SDS, 0.1% xylene cyanol, 0.1% 
bromphenol blue, and 50% glycerol). Aliquots were loaded onto an 8% native 
polyacrylamide gel in 0.5X TBE and electrophoresed for 1.5 h at 200V. The helicase 
activity was visualized and quantitated by phosphorimaging. 
hMCM8 
DNA helicase activity was measured in reaction mixtures (10 µl) containing 25 mM 
Hepes-NaOH (pH 7.5), 25 mM Na acetate, 10 mM Mg acetate, 1 mM dithiothreitol, 
100 µg/ml bovine serum albumin, 50 fmol labeled oligonucleotide and increasing 
amount of protein increasing amount of protein. After incubation at 37 °C or 25 °C 
for 60 min reactions were stopped and loaded as describe in the MthMCM section. 
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2.7.3 ATPase assay 
MthMCM proteins 
ATPase activity was measured in reaction mixtures (10 µl) containing 25 mM 
Hepes-NaOH (pH 7.5), 5 mM MgCl2, 1 mM dithiothreitol, 100 µg/ml bovine serum 
albumin, 1.5 nmol of ATP containing 2.5 µCi of [γ-32P]ATP and X or Y pmol of 
proteins (as monomers) in the presence or absence of 50 ng of ssDNA. After 
incubation at 60 °C for 60 min, an aliquot (1 µl) was spotted onto a 
polyethyleneimine cellulose thin layer plate, and ATP and Pi were separated by 
chromatography in 1 M formic acid and 0.5 M LiCl. The extent of ATP hydrolysis 
was quantitated by ImageQuant (GE Healthcare) analysis. 
hMCM8 
ATPase activity was measured in reaction mixtures (10 µl) containing 25 mM 
Hepes-NaOH (pH 7.5), 25 mM Na acetate, 10 mM Mg acetate, 1 mM dithiothreitol, 
100 µg/ml bovine serum albumin the presence or absence of 50 ng of ssDNA. After 
incubation at 37 °C or 25 °C for 60 min, an aliquot (1 µl) was spotted onto a 
polyethyleneimine cellulose thin layer plate, and ATP and Pi were separated by 
chromatography in 1 M formic acid and 0.5 M LiCl. The extent of ATP hydrolysis 
was quantitated by ImageQuant (GE Healthcare) analysis. 
2.7.4 Treatment of the hMCM8 protein samples with nucleotide 
analogues and DNA substrates. 
A protein sample at a concentration of 3.6 mg/ml was incubated in Buffer 25 mM 
Hepes-NaOH (pH 7.5), 150 mM Na acetate, 10 mM Mg acetate, 1 mM dithiothreitol, 
in the presence of 0.5 mM ATP, ssDNA or dsDNA. Incubation was carried out for 
15 minutes at room temperature (1 hour in the case of DNA). The sample was then 
spun down and filtered to remove any precipitate and loaded on a Superdex 200 PC 
3.2/30 gel-filtration column (GE Healthcare).  
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2.7.5 Topology footprinting assay 
Topology footprint assays were carried out in 15 l of reaction Buffer (50 mM Tris, 
pH 7.5, 1 mM DTT, 5 mM MgCl2, 30% (v/v) glycerol) containing 150 ng of DNA 
(5.7 nM). The DNA was incubated for 15 min at 37°C with increasing amount of 
MthMCM or with the same amount of sA mutant, followed by the addition of 20 
units of wheat germ Topoisomerase I. Reactions were stopped by incubating the 
reaction mixture with 5 l of Stop Buffer (1 mg/ml Proteinase K, 100 mM EDTA, 
1% SDS, 50% glycerol) for 15 min at 37°C. The samples were loaded on a 1.2% 
agarose gel in TBE 1× and electrophoresis was performed for 90 min at 11V/cm. 
Results were visualized after ethidium bromide staining. 
2.8 Electroblotting to PVDF membranes for protein 
sequencing 
Proteins separated via PAGE were transferred from a SDS-polyacrylamide gel to an 
PVDF membrane using the iBLot dry blotting system (Invitrogen). The 
electroblotting to the PVDF membranes was performed according to the guidelines 
provided by Proteomics Facility, University of Leeds (Leeds, UK). 
2.9 Electron microscopy sample preparation and data 
collection  
Samples were prepared by incubating for 10 mins at room T a solution containing 
both protein and dsDNA at a final concentration of 12.5 g/ml in Buffer containing 
30mM Tris HCl pH 7.5, 50 mM NaCl, 5mM MgCl2, 5 mM -mercaptoethanol. 
Negative-stain preparations were performed as follows: a sample of 4 l was 
incubated for 1 min on glow-discharged continuous carbon coated formvar copper or 
formvar nickel grids. The grid was washed with a 40 l drop of 2% uranyl-acetate 
solution, blotted and air-dried. Negative-stain EM of the wt and mutant nucleoprotein 
preparations was performed on either a Tecnai12 electron microscope (FEI) at an 
accelerating voltage of 120 kV, or a CM200 (FEI) field-emission gun electron 
microscope at an accelerating voltage of 200 kV. To enhance low-frequency 
components typical of the long stretches of dsDNA, a magnification of 11,500-
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27,500× and 5-10 m nominal defocus were used. For fibre diffraction studies, 
defocal pair micrographs were imaged on a CM200 electron microscope under low-
dose conditions, at a magnification of 50,000× and at 0.5 and 5 m nominal defocus. 
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3 Results and Discussion 
In this chapter the results obtained during my PhD project will be discussed. The 
chapter will be organized in two different sections.  
In the first part all the results of the work done with the archaeal proteins will be 
reported: the novel dsDNA/MCM interaction and the domain involved on it; the 
cloning, purification and initial biochemical characterization of the Glutamate switch 
(E switch) mutants and finally the work done with the C-terminal region of the 
archaeal MCM.  
In the second part all the work aiming to obtain soluble human protein will be 
described, and particularly the cloning and the test expression of hMCM8 fragments 
and the characterization of the biochemical properties of two fragments 
encompassing the N-terminal domain and the catalytic core, respectively.  
3.1 The Archaeal MCM proteins 
3.1.1 MthMCM/DNA: a novel interaction 
Studies in vivo on S. cerevisiae described two types of dsDNA/MCM2-7 interaction: 
an “associated” interaction, sensitive at high salt washes, and a more stable “loaded” 
interaction (Browers et al., 2004). Whereas various canonical models for the 
mechanism of hexameric helicases involved a ring encircling the DNA and can 
therefore easily account for the stable “loaded” complexes, no structural evidence 
was available for the associated complexes. 
Using Cryo-electron microscopy techniques A. Costa, in our laboratory, has carried 
out a 3D reconstruction of MthMCM proteins bound to a dsDNA substrate of 5600 
base pairs. Due the inability of the protein to load onto a long dsDNA segment in the 
absence of the appropriate loading factors, he managed to visualise a novel type of 
DNA/MCM interaction, with the dsDNA wrapping around N-terminal region of the 
ring, as opposed to the canonical binding of DNA within the central channel (Costa 
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et al., 2008; Figure 3.1). This interaction requires a conformational change of 
subdomain A (sA) located on the outer part of the MCM ring. 
  
Figure 3.1 Cryo-EM 3D reconstruction of MthMCM and long dsDNA. A) side and B) bottom 
view of the EM electron density map, fitted with the corresponding atomic models (N-term: green, 
AAA
+ 
: red, C-term: blue, dsDNA: orange). The N-terminal region is encircled by the dsDNA and a 
conformational change of subdomain A is required to account for the interaction.  
We suggested that this model may provide a structural framework for the initial 
(“associated”) interaction (Figure 3.2), prior to the loading and activation of the 
complex to function as a helicase at the fork (Costa et al., 2008). 
 
Figure 3.2 Schematic representation of two types of DNA/protein interaction. A) associated: the 
dsDNA wrapped around the protein; B) the protein is encircling the dsDNA, and the complex is 
therefore “loaded” ready for the helicase activity. 
In parallel to the structural biology work, I carried out some biochemical studies on 
the MthMCM system, to provide additional evidence for this proposal. 
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As the novel DNA/MCM interaction described is expected to have some effect on 
the dsDNA topology, I performed a topology footprinting assay, to test if incubation 
with MthMCM affects the degree of writhing of a negatively supercoiled plasmid 
(pUC18) (Figure 3.3). The same assay was performed with a deletion mutant missing 
subdomain A (ΔsA), to assess whether this part of the N-term region is involved in 
this protein-DNA interaction. 
 
Figure 3.3 Topology footprint assay. Plasmid DNA relaxation at saturating concentration of 
Topoisomerase I and in the presence MthMCM and in presence of ΔsA. In panel A the plasmid is 
incubated with increasing amount of MthMCM. Lane 1: 5.7 nM pUC18; lane 2: pUC 18 incubated 
with 1.8 µM (as hexamer) of MthMCM Lane 3: pUC18 incubated with 10 units of wheat germ 
Topoisomerase I. Lane 4-7; pUC18 incubated with increasing amount of MthMCM (0.09 µM-1.8 µM) 
for 15 minutes, followed by a 60 min incubation with Topoisomerase I. In panel B Lane 1: 5.7 nM 
pUC18.. Lane 2: pUC18 incubated with 20 units of wheat germ Topoisomerase I. Lane 3: pUC18 
incubated with 1μM of MthMCM, for 15 minutes, followed by a 60 min incubation with 
Topoisomerase I. Lane 4: the same experiment as in lane 3, where the ΔsA mutant is used instead of 
MthMCM. Lanes 5-6: pUC18 incubated with 1 µM of MthMCM or ΔsA, respectively. Different 
topological states can be visualised: (*) negatively supercoiled DNA; (**) partially relaxed DNA 
(***) totally relaxed DNA 
As we can observe from the gel in Figure 3.3, after incubation with MthMCM, a 
band corresponding to a partial relaxed (**) plasmid appeared. This effect is not 
detectable after incubation with the ΔsA mutant. These results confirms that the 
binding of MCM proteins influence the degree of supercoiling of dsDNA and that 
subdomain A is involved in this association with DNA (Costa et al., 2008).  
To further analyse the possible role of subdomain A, the DNA binding properties of 
the ΔsA mutant with DNA substrates of various lengths were measured (Figure 3.4). 
Although the ΔsA mutant is an active helicase, deletion of the sA impairs the binding 
of both ssDNA and dsDNA. Although ssDNA binding can be partly recovered by 
increasing the amount of protein (data not shown), no binding to short stretches of 
dsDNA (50 bp) is observed even at high protein concentration. It is possible to detect 
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some dsDNA binding for the ΔsA mutant when using longer dsDNA segments (250 
bp) (Costa et al., 2008).   
 
Figure 3.4 DNA binding activity. DNA binding properties of the ΔsA mutant: filter binding assays 
were performed using both the wt and ΔsA mutant protein, in the presence of A) a 50bp dsDNA 
substrate and (C) a 250 bp dsDNA substrate. The ΔsA mutant shows a decreased binding to both 
dsDNA (250 bp), whereas the binding to short stretches of dsDNA (50 bp) remains virtually 
undetectable 
Secondary structure comparison allowed to identify some similarity between the sA 
and a large number of dsDNA binding protein containing a HTH motif. All these 
proteins contact the dsDNA through a recognition helix and a lysine or arginine 
residue. The same cluster of helices and a similarly positioned arginine (R87) have 
been found in the sA (Figure 3.5). 
 
Figure 3.5 The crystal structure of the Genesis transcription factor bound to dsDNA (Jin et al., 
1999, PDB entry 2HDC). A) The recognition helix is highlighted in red, and the lysine of the basic 
loop in orange. B) The structure of subdomain A in the same orientation: the atomic models of proline 
61 and arginine 87 are shown in red and orange, respectively. 
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To assess the potential role of R87, I cloned, expressed and purified two mutants, 
where this residue was changed to an alanine or to a glutamic acid. The rational for 
the choice was that the mutation R87A is easier to be accommodated by the protein, 
but less likely to completely disrupt the dsDNA interaction; the reverse-charge 
mutation R87E may have some serious structural effect on the N-term structure, but 
if not disrupting the structure it is more likely to dramatically affect dsDNA binding. 
Both mutants could be expressed at high yield and displayed a similar behaviour to 
the wt in size-exclusion chromatography, confirming that the overall integrity of the 
structure was not affected (Figure 3.6 C).  
Biochemical experiments showed a decrease in the DNA binding properties of both 
the R87A and the R87E (with the Glu mutant showing a more marked effect, as 
expected), but the decrease was not dramatic (Figure 3.6 B). It has to be stated that in 
the presence of a protein showing multiple types of interaction with DNA, is very 
difficult to properly design an experiment to selectively dissect the effect of residues 
involved in one specific interaction. 
When we visualised both mutants in the presence of the 5,600bp dsDNA substrate, 
we observe that the proteins tend to form double rings or fibres and although DNA 
seems to engage with the protein, it is not as tense as in the presence of the wt protein 
(Figure 3.6 A). 
Biochemical assays (ATPase, helicase and DNA binding, topology footprinting) 
simply showed a general decrease of all the protein functions, suggesting that 
probably R87 is not a crucial residue for the dsDNA recognition or interaction, as 
predicted from the modeling studies, but it is still showing a significant effect. 
3.1.2 The Glu switch 
In addition to the canonical AAA+ sequence motifs, a feature called the “glutamate 
switch” (E switch) has been described that may provide a way to regulate the 
ATPase activity of this superfamily of proteins (Zhang and Wigley, 2008). A polar 
residue (typically an asparagine) can form a hydrogen bond with the glutamate 
residues of the Walker B motif (DExD), which in turn is critically involved in 
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orienting and polarizing a water molecule for the nucleophilic attack on the 
phosphate of the ATP substrate. This ensures that the ATPase activity is switched off 
unless the system is correctly assembled. The RuvBlike and HslUV/ClpX families 
possess an unusual version of the E switch, involving a Thr/Ser residue shifted by 
two residues from the standard Asn position.  
 
Figure 3.6 Biochemical and structural characterization of the R87 mutants. A) EM micrographs 
of  negative stained grids, to visualise the MCM/dsDNA interactions. The upper micrograph shows 
the R87A mutant with a 5600 bp dsDNA substrate. The lower micrograph shows the wt MthMCM 
with the same substrate. The red arrows indicate the DNA. Note that the DNA fibers are tense in 
presence of the wt protein, contrary to what is happening with the mutant, suggesting a different 
modality of DNA interaction. B and C) dsDNA binding properties of the MthMCM proteins, 12% 
SDS-Page of the proteins after the exclusion size purification step. 
A three-dimensional model based on the high resolution MCM structure from 
M. kandleri (Bae et al., 2009) suggests the intriguing possibility that the switch may 
be even more complex in MCM proteins, involving a conserved Thr/Ser residue 
located at the end of the second strand of the AAA+ fold core, in the canonical 
position of the usual Asn, as well as an additional Arg/Lys located two residues 
Chapter 3 Results and Discussions 
64 
 
further along the chain, where the RuvB-like switch is positioned. This residue is 
highly conserved either as an arginine or lysine, with the exception of MCM2 
proteins which have a conserved glutamine (Appendix 1). The loop containing both 
the Thr/Ser and the Arg/Lys residues immediately precedes helix 2 and the h2i that is 
postulated to interact directly with the DNA inside the channel, providing a possible 
route to switch on the ATPase activity upon substrate binding. (Figure 3.7).  
 
Figure 3.7. The glutamate switch in a variety of AAA+ ATPases (Zhang and Wigley, 2008). On 
the left panel the canonical switch as seen in the crystal structure of PspF (cyan) bound to the ATP 
substrate (Rappas et al., 2006); the switch consists of a conserved asparagine (located at the very end 
of the β-strand following the Walker B motif) holding the Walker B glutamate (DExD) in an inactive 
conformation in the absence of the substrate. In the RuvB-like family (yellow) the switch involves a 
threonine or serine residue located two residues downstream from the usual Asn position, as 
illustrated by the crystal structure of the human RuvBL1 protein (Matias et al., 2006). The 
MkaMCM2 crystal structure (green) shows that the position corresponding to the E switch in PspF is 
occupied by a residue that is a threonine or serine in the MCM family, whereas an arginine or lysine is 
located two residues downstream, in the position of the RuvBL1 E switch (Bae et al., 2009). Since the 
inactive MkaMCM2 does not have a Thr/Ser in the first position and has a histidine substituting the 
Walker B glutamate, the corresponding residues have been mutated in the figure to illustrate the 
situation found in the majority of the MCM sequence. 
Biochemical studies carried out in S. sulfolobus MCM have shown that both these 
residues have an effect on the degree and regulation of the helicase activity. The 
positively charged residue (K366) has been mutated in SsoMCM and the mutation 
completely abolishes the helicase activity and displays a modest reduction in the rate 
of ATP hydrolysis (Moreau et al., 2007). This is consistent with a role in regulating 
the helicase activity and coupling ATP hydrolysis with substrate binding. On the 
other hand the T364 mutant shows lower DNA binding and helicase activities 
compared with the wild type (wt), but the ATPase activity is higher (Mogni et al., 
2009), again arguing for a coupling role. 
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To experimentally confirm these structural insights, I cloned, expressed and purified 
two single mutants of MthMCM where both residues were mutated to alanine, 
S342A (SA) and K344A (KA), as well as a double mutant S342A/K344A (SKAA). 
All of them behave as the wt MthMCM in size exclusion chromatography, 
confirming that they don‟t affect the overall structure and stoichiometry (Figure 3.8). 
Unfortunately the proteins were heavily contaminated by DNA and therefore as yet 
unsuitable for the biochemical analysis. 
With hindsight the slight shift of the S342A mutant on the size exclusion 
chromatography profile (Figure 3.8) does correlate with a relatively lower level of 
DNA contamination.  
 
Figure 3.8 Exclusion size chromatography profiles. The chromatographic profiles of the wt 
MthMCM (red), the double mutant (blue), the S342A (magenta) and the K344A (brown). All proteins 
show the same behavior forming higher molecular weight complex (first peak, generally 
corresponding to the helical aggregates). The fractions corresponding to a double ring (second peak) 
were collected. 
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3.1.3  The C-terminal winged helix (WH) domain 
One of the aims of my project was to carry out structural and biochemical studies on 
the C-terminal region of the MCM proteins. When I started my work, no structure of 
this region was available, beside bioinformatics analysis detecting the putative 
presence of a WH motif in the archaeal sequences. Towards the end of my PhD, the 
NMR structure of the C-terminal domain of human MCM6 has been determined, 
showing indeed the presence of a WH domain (Wei et al., 2010). 
In order to get soluble recombinant protein I cloned, expressed and purified the 
C-term of the two best studied archaeal MCMs: MthMCM and SsoMCM. For 
MthMCM I subcloned the region from residue 582 to residue 666 (MthWH), to 
produce a 10 kDa protein, and for SsoMCM the region between residue 612 and 686 
(SsoWH) generating a protein of 8 kDa, as previously characterised by Barry et al. 
(2007). Each fragment was cloned in both the pProExHTa and pETM 30 expression 
vectors, to generate fusion proteins with either a 6His and a 6His-GST tag (Figure 
3.9), both cleavable with the recombinant Tobacco Etch Virus protease (TEV). Due 
to the higher levels of expression, the constructs with the Histidine tag at the 
N-terminus have been used for this work. 
  
Figure 3.9 SDS-page analysis of small scale expression tests. The small scale expression of 6His-
GST tagged C-term of MthMCM and SsoMCM; S: soluble fraction, W: wash, R. Ni
2+
 resin. The 
molecular weight of both constructs is nearly 36KDa. 
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Analysing the sequence alignment of various archaeal MCM, I realized that SsoWH 
as described in Barry et al. (2007) was missing a stretch of residues well conserved 
in the archaeal sequences (Figure 3.10); I therefore cloned a new slightly longer 
fragment (SsoE605) that includes these residues. As for the others, this fragment was 
inserted into ProExHTa 
 
Figure 3.10 Sequence alignment of archaeal MCM C-terminal domains. The C-terminal region 
(blue bar) of the archaeal MCM proteins were aligned. The red box indicates the conserved residues: 
in yellow are the identical amino acid, whereas in green the similar.. M. thermautotrophicum (Mth), S. 
solfataricus (Sso), A. fulgidus (Afu), M. acetivorans (Mac) T. acidophilum (Tac) 
For all the three proteins (MthWH, SsoWH and SsoE605) , large scale expression (6 
liters) was carried out using E. coli BL 21 cells grown in TB media; once the OD600 
value reached 1, protein expression was induced with 1 mM IPTG for 5 hours, and 
the over-expressed proteins purified by Nickel affinity chromatography. After 
cleavage of the 6His-tag using TEV protease, the protease as well as the uncleaved 
protein were removed by a second Nickel column. An ionic exchange step was 
initially included in the purification to remove any DNA contamination, but all the 
samples were clean after the two Nickel columns (as tested by gel analysis or 
absorbance at 260 nm), so this step was omitted. Finally the samples were analyzed 
on a size exclusion column (Superdex 75 10/30 or HiLoad Superdex 75 16/60). 
All the proteins eluted at a volume similar to the Ribonuclease A marker (Figure 
3.11), a protein of 13.7 KDa, and the profile does not change upon changing the 
concentration of the samples (data not shows), suggesting that they are likely to be 
monomeric. 
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Figure 3.11 Size exclusion chromatography analysis of the C-terminal domains. The profiles of 
the proteins under study (MthWH green, SsoWH blue, SsoE605 black) are compared to the molecular 
weight marker (red profile); Aprotin 6.5 kDA, Ribonuclease A 13.7 kDA, Carbonic anhydrase 29 
kDa. 
A DNA binding test was carried out and showed no DNA interaction with either 
ssDNA or dsDNA, as already reported in literature (Barry et al., 2007; Wei et al., 
2010). 
All the proteins were extremely soluble and it was possible to reach very high protein 
concentration (up to 90 mg/ml). The proteins were routinely concentrated to the 
desired level in 30 mM Hepes-NaOH pH 7.5, 150 mM NaCl, 10% Glycerol. After 
extensive crystallisation trails, the initial condition were modified by removing the 
glycerol, reducing the salt concentration (down to zero) and finally changing the pH 
of the solution (30 mM phosphate buffer pH 6.5, 50 mM NaCl).  
Crystallization trials were carried out via the sitting drop vapour-diffusion method 
using the Mosquito liquid handling robot (TTP LabTech‟s). Crystallisation drops 
contained either 1:1 or 2:1 volume ratios of protein to reservoir solution, 
respectively, with final drop volume of 200 or 300 nl (Figure 3.12) 
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Figure 3.12 Crystallization trials. A) Mosquito liquid handling robot (TTP LabTech‟s) available in 
our laboratory. B) schematic representation of the sitting drop vapour diffusion technique used in all 
mine screening. 
Initial crystallisation trials were set up at room temperature, at 4°C and 37°C using 
commercially available screens: Hampton Crystal Screen 1 and 2, Hampton 
PEG/Ion, Index Screen, SaltRX (all from Hampton Research), Wizard 1, 2 (Emerald 
Biosystems), Classic, Classic II, pH clear, pH clear II, comPAS, PACT and JCSG+ 
(Qiagen). These allowed the screening of many thousands of conditions for each 
protein. 
An initial irregularly-shaped crystal of SsoE605 (at a concentration of 35 mg/ml) was 
obtained in 0.2M Ammonium acetate, 0.1M Sodium acetate pH 4.6, 30% PEG 4000 
(Figure 3.13). A very large number of optimization attempts were carried out in order 
to reproduce the crystal and improve its morphology, using different seeding 
techniques, additive screens or “ad hoc” screens, with not satisfying results. It was 
impossible to test the diffraction property of the crystal as it dissolved during 
harvesting.  
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Figure 3.13 Irregular crystal obtained for SsoE605. The crystal (about 70 µm in lenght) was 
obtained in the following conditions: 0.2M Ammonium acetate, 0.1M Sodium acetate pH 4.6, 30% 
PEG 4000 
In the meantime, preliminary NMR studies were started in collaboration with the 
University of Verona (Figure 3.14 A and B). Two preliminary tests have been  
carried out so far: a 2D TOCSY (Total Correlation Spectroscopy) experiment, which 
shows the correlation of H atoms separated by two or three covalent bonds and is 
therefore useful for the correlation of the side chains of proteins and peptides, and a 
2D NOESY (Nuclear Overhauser Effect Spectroscopy) experiment that shows the 
correlation between H atoms separated by up to ~5 Å in space and therefore provides 
insights into the 3D structure. 
The numbers of the peaks and their position indicate the possible presence of helices 
and short stretches of β-sheets for all the constructs, structures consistent with a WH 
motif. The protein will be enriched with the proper isotopes for further NMR 
analysis. 
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Figure 3.14 NMR and Crystallization results. The panels A and B are the TOCSY and 2D NOESY 
of the MthWH, 0.5 mM protein in 30 mM phoshate buffer pH 6.5, 50 mM NaCl have been used for 
the analysis with a Bruker avance spectrometer at 600.13 MHz.  
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3.2 The eukaryotic MCM proteins 
3.2.1 hMCM8 protein 
Analysing the sequence alignment of various MCM8 with the structurally 
characterised archaeal MCM proteins (see Appendix 1 and 2), the putative 
boundaries of the domains were identified. The corresponding fragments were cloned 
into a pProExHta expression vector in order to obtain proteins with a 6 histidines-tag 
at the N-terminus (Figure 3.15). 
 
Figure 3.15 Schematic representation of the primary sequence of hMCM8 and the constructs 
produced during this work. The putative location of the domain boundaries, as inferred from the 
structure of archaeal MCM proteins is shown (green: N-term; red: AAA+; blue: C-term). The start and 
end points that have been used in the cloning strategy are indicated with triangles and labelled by the 
residues at the beginning or end of the cloned fragment (start points are shown above, end points 
below). Their combination generate 17 different constructs, as shown below 
Using the classical cloning strategy with restriction enzymes (with BamH1 and 
Xba1) the fragments were generated by PCR, using as template the pTrc-HisC-
hMCM8 plasmid kindly provided by Dr F.M. Pisani (IBP-CNR, Naples). The 
fragments and the vector have been digested with the appropriated restriction 
enzymes and then ligated using the T4 ligase. A colony PCR screening was 
performed to identify the positive clones, that were subsequently sequenced (Table 
3.1). Constructs have been used to transform E. coli cells and a systematic screening 
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for optimal expression has been carried out, by testing the effect of different bacterial 
strains (BL 21 , BL 21 codon+, BL 21 gold, BL 21 star, BL 21 Rosetta2, B834), 
expression temperatures (18°C, 24°C, 30°, 37°C), expression times (5 hs, O.N, 24 hs, 
48 hs), growing media (LB, TB) and induction methods (IPTG or auto-induction). 
Construct Name Starting and ending 
residues 
Molecular weight 
(kDa) 
hMCM8_1 M1-Q368 42.5 
hMCM8_2 M1-S372 43.1 
hMCM8_3 M1-S764 86 
hMCM8_4 M1-M840 94.7 
hMCM8_5 S67-Q368 35 
hMCM8_6 S67-S372 35.4 
hMCM8_7 S67-S764 78.4 
hMCM8_8 S67-M840 87.1 
hMCM8_9 P203-Q368 19.4 
hMCM8_10 P203-S372 19.8 
hMCM8_11 P203-S764 62.9 
hMCM8_12 P203-M840 71.5 
hMCM8_13 S373-S764 44.2 
hMCM8_14 S373-M840 55.9 
hMCM8_15 G380-S764 43 
hMCM8_16 G380- M840 54.7 
hMCM8_17 Q765- M840 9.6 
Despite the wide screening, most of the constructs were not expressed at high levels 
or insoluble in the examined conditions and only 2 of them were soluble: hMCM8_2 
(1-372 aa) corresponding to the N-terminus of the protein, and hMCM8_14 (373-840 
aa) that includes the AAA+ and the C-terminal domain of the protein.  
The optimised conditions for the two successful constructs are the following: 
 hMCM8_2 (1-372 aa): BL 21 Codon + RIPL cells, grown in LB broth, 
induced with 0.5 mM IPTG, then grown for 24 hs at 25°C   
Table 3.1 Histidine-tagged constructs summary. The table summarises all the hMCM8 constructs 
and their molecular weights  
Chapter 3 Results and Discussions 
74 
 
 hMCM8_14 (373-840 aa): Rosetta 2 cells, grown in TB Broth, induced with 
0.5 mM IPTG, then grown for 24 hs at 25°C  
As fragments hMCM8_7 (S67-S764), hMCM8_8 (S67-M840), hMCM8_11 (P203-
S764), hMCM8_12 (P203-M840) were systematically insoluble (Figure 3.16), a new 
cloning strategy has been adopted: I decided to clone these fragments with Maltose 
Binding Protein (MBP) as fusion partner, as the MBP tag has been shown to help the 
folding of recombinant proteins, thereby increasing their solubility.  
  
Figure 3.16 8% SDS-Page of a small scale expression test. The small scale expression test 
performed with BL21 codon + RIPL E coli strain. For all the constructs tested the insoluble (I.S) and 
soluble (S) fractions are loaded on the gel and compared with a totat extract before the IPTG induction 
(B.I.). The red circles show the proteins of interest in the insoluble fractions 
As the vector chosen (pETM41, EMBL) absolutely required that the restriction site 
of the N-terminal primer was NcoI, the endogenous NcoI restriction site present in 
the hMCM8 DNA sequence (position 1597) was removed with the Quick-change 
point mutation system (Stratagene). The new construct, called hMCM8-noNco, was 
then used as template for the PCR. The restriction enzymes selected for the cloning 
are NcoI and NotI. In Table 3.2  the information on the MBP-fusion constructs are 
summarised. 
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Construct Name Starting and ending 
residues 
Molecular weight 
(kDa) 
MBPhMCM8_7 S67-S764 121.4 
MBPhMCM8_8 S67-M840 130.1 
MBPhMCM8_11 P203-S764 105.9 
MBPhMCM8_12 P203-M840 114.5 
Table 3.2 MBP-tagged construct summary. The table summarises all the MBPhMCM8 constructs 
and their molecular weights (including the 6H-MBP tag of 43 kDa) 
Small scale expression tests were performed with the MPB constructs and in all cases 
the best results were obtained using BL 21 codon + RIPL E. coli strain in an 
autoinduction TB broth (TB broth, 0.8% Glycerol, 0.5%  Lactose, 0.015% Glucose, 2 
mM MgSO4) (Figure 3.17). Small scale purification tests were performed using MBP 
affinity column and the elution steps carried out with 10 mM Maltose. Similarly to 
the truncated forms (see below), these constructs are extremely sensitive to 
proteolysis. 
  
Figure 3.17 8% SDS-Page small scale expression of MBP construct. The pellet from 50 ml of 
culture has been resuspended in 5ml of a buffer containing 20 mM Tris pH 7.4, 200 mM NaCl, 1 mM 
EDTA, 5% Glycerol, 2 mg/ml lysozyme, 2.5 mM PMSF. After sonication and centrifugation, the 
supernatant is loaded on 1 ml MBPhitrap column. The elution performed with 10 mM Maltose. The 
red circles show the proteins of interest fused with MBP (43kDa). For each protein the Total Extract 
(Ex) Flow through (Ft) and the Elution (El) have been loaded. 
In the meantime, large scale expression tests (1 Liter) were carried out for the soluble 
His-tagged 8_2 (corresponding to the N-terminal region of the protein) and the 8_14 
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(containing both AAA+ domain and C-terminal region) fragments. The first step 
consisted in an affinity Nickel column, a second step involved ionic exchange 
chromatography and a final size exclusion column (Superdex 200) was used to check 
the oligomeric state of the protein. 
Both fragments were very sensitive to salt concentration, precipitating when the 
concentration of NaCl was lower than 300 mM. After the last step of purification 
both proteins contained a significant number of bands corresponding to impurities 
and/or proteolysis products (Figure 3.18). 
N-terminal sequence analysis performed by Dr. Keen at the Proteomics Facility of 
Leed University, helped to understand the nature of the additional protein bands 
present in the samples. Bands running on an SDS gel at a molecular weight of 
approximately 45 kDa and 33 kDa (Figure 3.18, bands in the red boxes) 
corresponded to a protein with the same N-terminal amino acids as the unproteolysed 
8_14 construct, indicating the loss of a C-terminal fragment. A 25 kDa band (Figure 
3.18, green box) present in both samples is due to contamination by an E. coli 
protein. This contaminant is a chaperone protein (the peptidyl-prolyl cis-trans 
isomerase FKBP): containing a His-rich domain with high affinity for Ni
2+
 ions, it is 
a typical contaminant of proteins purified by Nickel affinity chromatography.  
 
Figure 3.18 12% SDS-Page of fractions from size exclusion chromatography. After a gel filtration 
run the fractions have been assayed by SDS-Page. The red arrows indicate the protein of interest 
(hMCM8_14, 52KDa and hMCM8_2, 43Kda). Both proteins samples include contaminants (green 
boxes) and proteolytic fragments (red boxes). 
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In order to obtain proteins with a higher level of purity, a new purification protocol 
was devised. The metal affinity purification step was modified by using Co
2+
 (which 
has a lower affinity for histidine) instead of Ni
2+
 to increase selectivity and therefore 
remove the more loosely bound FKBP protein. The addition of Mg
2+
 and ATP to the 
purification buffer was introduced to avoid any GroEL contamination. An extra 
washing step with high salt concentration (1 M NaCl) was carried out to reduce 
nucleic acid contamination.  
Preparative size exclusion chromatography was used as a second step for the 
hMCM8_14 deletion mutant (Figure 3.19).  
A heparin affinity column was used for hMCM8_2 (the protein eluted at high salt 
concentration, close to 2M NaCl), followed by size exclusion chromatography. 
Although the 8_2 construct tends to form aggregates, both protein eluted in a dimeric 
form. 
 
Figure 3.19 12% SDS-Page of fractions from size exclusion chromatography. The new 
purification strategy allows to remove the nucleic acid contamination as well as the GroEL 
contamination, unfortunately the protein are still proteolysed. 
The new purification protocol allowed the removal of traces of chaperones and 
nucleic acid contamination. Unfortunately, despite increasing the concentration of 
protease inhibitors (Figure 3.20), I haven‟t been able to avoid proteolysis, especially 
in the case of hMCM8_14.  
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Figure 3.20 12% SDS-Page of the His-tagged hMCM8 soluble constructs. The SDS-Page of both 
hMCM8 deletion mutant after all the purification steps. The hMCM8_14 construct appears really 
sensitive to proteolysis. 
A preliminary biochemical characterization for the both truncated forms was 
performed.  
First, the oligomeric state of both constructs was assessed in presence of different 
substrates (nucleic acids or nucleotides) in 25 mM Hepes-NaOH (pH 7.5), 150 mM 
Na acetate, 10 mM Mg acetate, 1 mM dithiothreitol. The protein was incubated for 
one hour with ssDNA or dsDNA, at a DNA/protein ratio of 1.5/1 in molarity (at 
room T) and then the samples were injected in a Superdex 200 3.2/30 column. For 
the hMCM8_14 which comprises the AAA+ domain, incubation with 0.5 mM ATP 
for 15 minutes at room T was also performed. In all instances the size exclusion 
chromatography profile did not reveal any indication of substrate-induced 
oligomerisation, as the proteins maintained the dimeric state (Figure 3.21). The small 
shoulder of about 44 kDa visible on the chromatogram in figure 3.21 (green arrow) 
probably suggests the presence of dynamic equilibrium between the monomeric and 
dimeric forms of the protein or may be due to the formation of dimers of the 
proteolytic fragments present in the preparation. 
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Figure 3.21 Analytical exclusion site profile of hMCM8_14 in the presence of ATP. The 
oligomeric state of the proteins of interest is tested with different substrate. The protein (30 µM) was 
incubated for 15 min a room temperature with nucleotide (ATP) or with DNA substrates for 1hour in 
25 mM Hepes-NaOH (pH 7.5), 150 mM sodium acetate, 10 mM MgCl2, 1 mM dithiothreitol. Here 
are compared the profiles of the hMCM8_14 (red) and the profile of hMCM8_14+ATP (blue) and 
molecular weight marker (grey, including Ovalbumin: 44 kDa and Aldolase: 158 kDa. 
The experiment described above has a number of possible pitfalls. Given the 
relatively low affinity of MCM proteins for DNA, as shown by the large excess of 
protein needed to shift the DNA in most EMSA experiments carried out on archaeal 
MCM proteins (Kasiviswanathan et al., 2004; Barry et al., 2007), it is possible that 
hexamerization or in general oligomerisation may be detected only in the presence of 
a large excess of substrate, not feasible in the above described experiment. Due to the 
inherent instability of the protein, it was not possible to reach higher concentration 
and the limits of the instrument may not permit the detection of very small amounts 
of oligomers.  
Electrophoretic mobility shift assays (EMSA) were performed to evaluate the DNA 
binding properties of both the N-terminal and C-terminal domain. The results show 
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that both proteins bind radiolabeled single stranded DNA (ssDNA) forming multiple 
DNA/protein complexes, possibly due to the presence of different proteolytic 
fragments and oligomeric states (Figure 3.22)  
 
Figure 3.22 EMSA assay with a ssDNA. A) Increasing amount of hMCM8_2 (from 1 to 16 pmol as 
monomer) were incubated with 50 femtomol of ssDNA (41bases) for 1h at room temperature in a 
DNA binding buffer (25 mM Hepes pH 7.5, 25 mM NaAcetate, 10 mM MgAcetate, 1 mM BME, 0.1 
mg/ml BSA, 10 µl reaction). The sample were loaded onto  a native 8% polyacrylamide gel, run in 
0.5X TBE buffer for 40 min @ 100V. The (*) indicates the DNA/protein complexes. B) The ssDNA 
ability of both truncated form of the hMCM8 has been quantified, showing a very similar behaviour 
for both hMCM8_2 (blue) and hMCM8_14 (red).  
Generally MCM deletion mutants tend to show a relatively low affinity for DNA, 
loosing the synergic effect due to the presence of multiple DNA binding domains. 
For example, systematic studies of the DNA binding properties of various deletion 
mutant of MthMCM and SsoMCM (;) showed that the N-terminus of MthMCM is at 
least 8 times less efficient of the wt in shifting a ssDNA substrate (Kasiviswanathan 
et al., 2004), and the truncated form of SsoMCM even less efficient (a SsoMCM 
construct including the AAA+ and the C-terminal domain, equivalent to hMCM8_14 
is 100 times less efficient compared to the full-length protein, Barry et al., 2007). 
The DNA binding affinity of the two deletion mutants of hMCM8 presented in this 
study is therefore in line with the above results. Preliminary experiments also show 
that both proteins bind dsDNA and fork-like substrates with comparable affinities. 
Since the 8_14 construct contains the ATPase domain, assays to measure the ATPase 
catalytic activity have been performed. As shown in Figure 3.23, the 8_14 deletion 
mutant displays a significant ATPase activity and such activity is stimulated by 
ssDNA, as expected for a helicase. As in AAA+ proteins the ATP binding pocket is 
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located at the interface between subunits and requires residues from two adjacent 
monomers, these results are consistent with the dimeric state of the protein. 
 
Figure 3.23 8_14 ATPase assay. A) Increasing amounts of hMCM8_14 protein (shown below the gel 
in pmol as monomer) have been incubated with 5 mM ATP for 30 min @ 37°C in a 50 mM Tris pH 
7.9, 10 mM MgAcetate, 0.5 mg/ml BSA,2 mM BME (10µl). B) ATP hydrolysis activity of the 
hMCM8_14. C) the same experiment described in A) in presence or absence of 200 fmol of a ssDNA 
(41bp oligonucleotide) in a 50 mM Tris pH 7.9, 10 mM MgAcetate, 0.5 mg/ml BSA,2 mM BME. D) 
comparison of the ATP hydrolysis activity of the hMCM8_14 without (blue) or with (magenta) 
ssDNA 
Due to time limitations, the experiments described above need to be considered as 
preliminary, and more work is needed to optimise the assays for a full 
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characterization of both truncated forms of hMCM8 and to better investigate their 
biochemical properties.  
For example no helicase activity has so far been detected. A possible explanation 
may lie in the need of optimisation of the experimental conditions. Since the helicase 
activity should require an intact hexamer, another possibility is that the lack of DNA 
unwinding is due to the fact that the deletion fragments loose the ability of 
oligomerise, as I haven‟t been able to detect any hexamerization (for both deletion 
mutants) in the presence of substrates such as ATP and DNA. A more interesting 
hypothesis is that the complex may require the presence of additional physiological 
partners. 
Although the information that I have so far obtained are still preliminary, my 
constructs represent the first deletion mutants of hMCM8 (obtained in E. coli cells, 
so without post-transcriptional modification) showing biological activities. Site 
directed mutants for each domain have been designed and further biochemical and 
structural investigations will be performed. 
3.2.2 Human MCM9 protein 
The bioinformatics analysis performed by Liu et al., (2009) demonstrated that both 
MCM8 and MCM9 are evolutionary linked, being both present or absent in each 
organism, with the exception of Drosophila, as previously discussed. This also 
suggests a functional link between the two MCM protein, as both of them do not 
interact with the helicase 2-7 complex.  
In order to analyse this potential interaction, I focused my attention on human 
MCM9 (hMCM9). As no cDNA is commercially available for the full-length protein 
(only a cDNA encoding for the N-terminal part of the protein from the residue 1 to 
391 – described in Yoshida (2005) - can be purchased) I tried to produce cDNA 
starting from messenger RNA present in the cells using Reverse Transcriptase (RT) 
PCR.  
No information about the specific expression patterns of hMCM9 in tissues and/or 
cell-cycle stages is available. As generally the MCM protein are only expressed in 
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proliferating cell, I used total RNA from different cancer cell lines (Table 3.3) kindly 
provided by Prof. G. Del Sal.  
Table 3.3 List of cell lines used for hMCM9 RT PCR. The total RNA extract from these cell lines 
has been used for the first strand synthesis reaction using a d(T)16 oligonucleotide. The PCR reaction 
are then performed with gene specific primers. 
After many attempts using both oligo d(T) as well as gene-specific 3' UTR primers, 
it has only been possible to produce the cDNA encoding for the N-terminal region of 
the protein (Figure 3.24). Whether this is due to technical problems or to the possible 
presence of isoforms within the cell lines examined is still unclear. 
To overcome these problems, the synthetic hMCM9 gene has been purchased 
(GeneArt) and the cloning of different domains is in progress using a restriction free 
(RF) cloning technique. RF cloning is a two-steps process. The two strands of the 
PCR product obtained in the first stage are used as “mega primers” for the second 
stage of amplification. In the second stage, the PCR product and the target vector are 
mixed and, following amplification reaction, the gene of interest is integrated into the 
circular vector into a pre-defined position.  
A similar strategy to the cloning of deletion fragments of hMCM8 was implemented, 
using the structural information from the archaeal homologues to infer the domain 
boundaries of hMCM9 (Figure 3.24) 
Cell line Tissue 
MCF10A Mammary gland  
HepG2 Liver hepatocellular carcinoma 
HeLa Cervical cancer 
A549 Lung adenocarcinoma 
SK-N-AS Neuroblastoma 
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Figure 3.24 hMCM9 cDNA synthesis. A): schematic representation of hMCM9 compared with the 
structure of MthMCM (colored part). Numbers and arrows indicate start and end point of the domain 
that are used in the cloning strategy; the combination of all of them allows the formation on 17 
constructs. B and C): from total RNA of HeLa cells cDNA synthesis of hMCM9. A pair of primer for 
β-actin is used as positive control. The number of the constructs are referred to the scheme in panel A. 
All the fragments are being cloned into a pETSumo vector (Invitrogen), expressing 
the protein as a fusion with the protein SUMO, under the control of the antibiotic 
kanamycin. The choice of the vector was based on the following considerations: 
1. the presence of the SUMO-tag has been shown to improve the solubility of 
“difficult” proteins. 
2. the kanamycin resistance permits the co-expression of each hMCM9 protein 
fragment with the equivalent fragment from hMCM8 constructs (pProExHTa, 
ampR); the presence of a physical interaction could be detected by pull-down assays 
and may strongly contribute to enhance the solubility of both potential partners. 
Currently a number of constructs have been obtained (Figure 3.25) and they will 
soon be tested for protein expression and solubility, either alone or in co-expression 
with hMCM8 equivalent fragments. 
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Figure 3.25 colony PCR screening of hMCM9 constructs. A colony PCR screening was performed 
to check positive clones. All the PCR were performed using the L109/I278r as pair of primers. The 
number of the construct is the same used in the Figure 3.24 A. 
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4 Conclusions and Future plans 
4.1 Archaeal MCM proteins 
The archaeal MCM proteins are good model to study the more complex 
eukaryoticorthologues. MCM proteins have been characterized over the years 
structurally and biochemically, but there are still many questions open: for example, 
how the protein is loaded onto the replication origin or how the helicase is unwinding 
the DNA duplex. 
Following the results obtained in our laboratory by A. Costa, who obtained a 3D EM 
reconstruction of a novel mode of MCM/dsDNA interaction, I carried out a 
biochemical study to confirm and support the structural work. I have been able to 
demonstrated the effect of this interaction on the topology of the DNA and to 
confirm the essential role of subdomain A (Costa et al., 2008). This topological 
stress may represent the contribution of the MCM protein to the melting of the origin 
and the consequent formation of the replicative bubble. An intriguing hypothesis is 
that MCM helices that have been previously visualised and studies by EM (Chen et 
al., 2005) may have a physiological role similarly to the one proposed for the 
bacterial initiator DnaA. Preliminary work from our laboratory (Costa et al., 2008) 
suggested that such helices are more prevalent in samples that are highly 
contaminated with endogenous DNA. At the beginning of my PhD I have been 
involved in the attempt to characterise from a structural point of view such 
MCM/DNA helical fibers, but the lack of reproducibility of the samples hindered 
progress. More work directed at the identification of experimental conditions that 
allow the preparation of reproducible samples may help to shed light on the putative 
role of MCM proteins in the initiation of DNA replication. 
The C-terminal region of the MCM protein was the less characterized of the enzyme 
domains. To obtain structural and biochemical data on this region I have produced 
three expression constructs (one to produce the C-terminal region of MthMCM and 
two corresponding to the C-terminus of SsoMCM) and optimise the expression and 
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purification protocols to obtained up to hundreds of milligrams of highly purified 
proteins. The DNA binding proteins of the three proteins have been examined, but no 
evidence for an interaction has been detected. These recombinant proteins have been 
used for “high throughput” crystallisation screenings using a robotic platform, to 
obtain high-resolution diffracting crystals. Despite the initial appearance of an 
irregularly shaped crystal, all the extensive attempts to reproduce and optimize the 
shape and the diffracting qualities have so far been unsuccessful. Due to the 
extension and breath of the crystallisation and optimisation experiments that have 
been carried out over more than two years, we reached the conclusion that the 
intrinsic flexibility of the C-terminal domain is probably incompatible with the 
formation of a regular ordered three-dimensional lattice. 
We have therefore decided to adopt an alternative structural biology approach and 
started a collaboration with Prof. H. Molinari, at the University of Verona. The 
proteins is now been used for NMR experiments. Preliminary results are compatible 
with a winged helix structure as predicted for the archaeal sequences and as 
demonstrated also for the human orthologue from MCM6 (Wei et al., 2010). Future 
work include the expression of the protein in isotope-enriched media for more 
detailed NMR analysis, enabling the determination of the 3D structure of the C-
terminal domain of archaeal MCM.  
AAA+ proteins need to harness the energy from ATP hydrolysis to carry out 
mechanical work; to ensure their efficiency, it is therefore important to avoid the 
useless turn-over of ATP in the absence of the suitable substrate. This task is 
generally achieved via what has been described as the “Glu switch”: an amino-acid 
residue (typically an asparagine) that holds the catalytic Walker B glutamate in an off 
position, unless the substrate is present (Zhang and Wigley, 2008). An examination 
of the structure and sequences of MCM proteins suggests the presence of a more 
complex 3-residue switch, involving a conserved positively charged residue 
(Arg/Lys) and a polar residue (Thr/Ser).  
To confirm this hypothesis, I have mutated the putative Glu switch residues to 
alanine in MthMCM, producing three mutant forms: Ser 342 -> Ala (S342A), Lys 
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344 -> Ala (K344A) and a double mutant, including both changes (SKAA). The 
three mutant proteins have been expressed and purified to homogeneity, showing a 
similar behaviour to the wild-type, confirming that the integrity of the complex has 
not been affected. However, a preliminary biochemical analysis suggested a high 
(and variable) level of DNA contamination in the sample preparation, which does not 
allow the proper comparison of the relative properties of the mutants. A new 
purification protocol will be set up in order to remove the nucleic acids 
contamination, to verify the role of the above mentioned residues in coordinating 
DNA binding and ATPase activity. 
4.2 Human MCM8 
In addition to the universally conserved eukaryotic MCM2-7 complex, two MCM 
proteins (MCM8 and MCM9) are present in a variety of eukaryotic organisms, but 
hardly any biochemical or cell biology data is available to elucidate their function 
within the cell.  
I therefore embarked into a long and extensive project to obtain soluble truncated 
form of hMCM8, by systematically cloning a large number of MCM8 fragments (17) 
into a variety of bacterial expression vectors, and testing their ability to produce 
soluble proteins under a range of experimental conditions, including different cell 
strains, expression temperature and media. I have manage to obtain soluble protein 
from two deletion mutant: one corresponding to the N-terminal domain of the protein 
and one that contains the catalytic domain and the C-terminal domain.  
As a preliminary step the biochemical properties of the fragments have been 
determined. Both proteins possess ssDNA binding activity comparable to the DNA 
binding affinity of archeal MCM properties. The catalytic core shows a ATPase 
activity stimulated by DNA. Both proteins tends to form dimeric structures and the 
stoichiometry is not changing in presence of nucleotide or DNA. Although no 
helicase activity or formation of hexameric structures have been detected so far, 
these two proteins are the first hMCM8 fragment produced in E. coli cells and 
showing biochemical activities. The lack of evidence for an hexameric structure 
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(which is expected to be essential for the MCM helicase activity) may be due to a 
lack of synergic effects in the separated domains but also to the absence of potential 
partners.  
Further work will be carried out on the MCM8 deletion mutants, with the aim of : 
1) further characterise and dissect the biochemical activity of the soluble fragments, 
by designing a variety of site-directed mutants targeting the residues which have 
been shown to be involved in DNA binding, ATP binding, ATP hydrolysis, helicase 
activity in the well-studied archaeal MCM orthologues. Such mutants have been 
already designed and the primers for the site-directed mutagenesis experiments 
already purchased. 
2) optimise the expression protocols for some other constructs and fragments 
3) optimise the purification protocol in order to control proteolysis and increase the 
purity of the protein sample to the level required for structural studies. 
Analyzing the evolution of the MCM8 proteins and MCM9, which are either both 
present or both absence in almost all organisms, it seems evident that these proteins 
are covelutionary related, making it likely that are also functionally related. An  
intriguing possibility is that the two proteins form a hetero-hexameric ring, and such 
ring may be essential for the helicase activity. 
In order to assess this hypothesis I started the cloning and the test expression of a 
large number of hMCM9 fragments and full-length protein. In addition to test the 
production of soluble hMCM9 fragments and to characterise them, the constructs 
have been designed to allow the co-expression with the hMCM8 fragments described 
above. All these proteins will therefore be co-expressed with hMCM8 to test the 
formation of functional complexes. 
 
.  
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Appendix 1 Sequence alignment of MCM 
proteins 
Figure A.1 Sequence alignment of MCM homologues. 
Protein sequences of the MCM2 homologue from Methanopyrus kandleri (metka), the MCM 
homologues from Methanothermobacter thermautotrophicus (metth), Archaeoglobus fulgidus (arcfu), 
Thermoplasma acidophilum (theac), Sulfolobus solfataricus (sulso), Aeropyrum pernix (aerpe), the 
MCM2-7 homologues from Saccharomyces  cerevisiae (yeast), Schizosaccharomyces pombe (schpo), 
Xenopus laevis (xenla), Homo sapiens (human), Drosophila melanogaster (drome), and the MCM8-9 
homologues from H. sapiens and X. laevis were aligned using the program ClustalW and manually 
adjusted to obtain a structure-based alignment, using the atomic structure of the N-terminal domain 
of MthMCM (PDB entry 1LTL) and the AAA+ domain of the MkaMCM as reference. Secondary 
structure elements are shown as rectangles (-helices) and arrows (-strands) and are colour coded 
as belonging to the N-terminal domain (green) or the AAA+ domain (red). A coloured line above 
indicated the subdomain structure, with subdomain A in yellow, subdomain B in teal, subdomain C in 
green, subdomain / in red, subdomain  in orange. The location of some of the biochemically 
important motifs is indicated (NBH, Walker A and B, h2i, PS1BH, Sensor I and II, Arg finger). 
Highlighted in cyam are the residues coordinating the Zn atom, in yellow the proline and arginine 
discussed in the text (Pro61 and Arg87 in MthMCM) 
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Appendix 2 Sequence alignment of MCM8 
and MCM9 proteins 
Figure A.2  Sequence alignment of MCM8 and MCM9 homologues. 
Protein sequences of the MCM8 and MCM9 orthologues from human (HUMAN), Xenopus laevis 
(XENLE), mouse (MOUSE), Apis mellifera (APIME), Trichoplax adhaerens(TRIAD) Dictyostelium 
discoideum AX4(DICDI), Monosiga brevicollis MX1 (MONBR), Tribolium castaneum (TRICA), 
batrachochytrium dendrobatidis (BATDE), Daphnia pulex (DAPPU), Ciona Intestinalis (CIOIN), 
Capitella sp (CAPSP), lottia gigantea (LOTGI) Nemotostella vectensis (NEMVE) were aligned using 
the program ClustalW and manually adjusted to obtain a structure-based alignment, using the atomic 
structure of the N-terminal domain of MthMCM (PDB entry 1LTL) and the AAA+ domain of the 
MkaMCM as reference. The domain structure is indicated by the same scheme described in Appendix 
1. Green triangles indicate the starting point of the construct produced for this work, whereas the red 
triangles indicate the ending point. In yellow are highlighted crucial residues,. The canonical motifs 
shared by all MCM proteins are enclosed by boxes.  
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Appendix 3 Reagents, buffers and solutions 
Reagents used  
PfuTurbo DNA polymerase and PfuTurbo buffer were obtained from Stratagene. 
dNTPs, restriction endonucleases, restriction buffers, BSA for restriction digestions 
and Calf Intestinal Phosphatase (CIP) were from New England Biolabs. The Rapid 
DNA Ligation Kit was purchased from Roche. IPTG (dioxan free) and DTT were 
from Melford Laboratories. Lysozyme (from chicken egg white), glutathione 
(reduced form), thrombin (lyophilised powder), PMSF, βΜE, BSA (for Western 
Blots) and gel-filtration molecular weight markers were all purchased from Sigma. 
Benzonase was from Merck.  
All other buffers, salts and reagents used for the preparation of solutions were 
purchased from Sigma.  
Composition of solutions  
Media  
LB medium (LB): LB powder (Lennox L Broth, Sigma) was dissolved in deionised 
water (20 g per L of water) and autoclaved for 20 min at 121ºC. The medium was 
stored at room temperature and the necessary antibiotics were added to the specified 
final concentrations prior to use.  
Terrific broth (TB): Terrific broth (Modified, Sigma) was dissolved in deionised 
water (47 g per L of water) and 8 ml glycerol per L of medium was also added prior 
to autoclaving (20 min at 121ºC). The medium was stored at room temperature and 
the necessary antibiotics were added to the specified final concentrations prior to use.  
Autoinduction Terrific broth (TB): Terrific broth (Modified, Sigma) was dissolved 
in deionised water (47.6 g per L of water) and 8 ml glycerol, 5gr of Lactose, 0.15gr 
of Glucose, 0.49 gr of MgSO4 heptahydrate per L of medium was also added prior to 
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autoclaving (20 min at 121ºC). The medium was stored at room temperature and the 
necessary antibiotics were added to the specified final concentrations prior to use.  
LB Agar and agar plates: 5.25 g of LB agar powder (Lennox L agar, Sigma) were 
added to 150 ml deionised water and autoclaved for 20 min at 121ºC. The medium 
was allowed to cool to 50ºC before adding antibiotics to the specified final 
concentrations. 20 ml of medium were poured into 85 mm petri dishes. If necessary, 
the surface of the medium was flamed with a Bunsen burner to eliminate bubbles. 
The medium was left to harden for one hour and the agar plates were stored at 4ºC 
for ≤ 1 month.  
Antibiotic stock solutions (1000x)  
Ampicillin: 1 gr of ampicillin sodium salt (Melford Laboratories) were dissolved in 
10 ml deionised water, filter-sterilised and stored at -20ºC. Ampicillin was added to 
growth medium to a final concentration of 50 μg/ml.  
Kanamycin: 50 mg of kanamycin monosulphate (Melford Laboratories) were 
dissolved in 10 ml deionised water, filter-sterilised and stored at -20ºC. Kanamycin 
was added to growth medium to a final concentration of 25 μg/ml.  
Chloramphenicol: 340 mg chloramphenicol (Sigma) were dissolved in 10 ml 
ethanol and the aliquots were wrapped in foil and stored at -20ºC. Chloramphenicol 
was added to growth medium to a final concentration of 34 μg/ml.  
Buffers used for the preparation of competent E. coli cells  
TFB1: 100 mM RbCl, 50 mM MnCl
2
, 30 mM potassium acetate, 10 mM CaCl
2
, 
15% glycerol, pH 5.8 (adjusted with acetic acid). The solution was filter-sterilized 
and stored at 4ºC.  
TFB2: 10 mM MOPS, 10 mM RbCl, 75 mM CaCl
2
, 15% glycerol, pH 6.8 (adjusted 
with KOH). The solution was filter-sterilized and stored at 4ºC.  
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Buffers used for the purification and crystallisation of recombinant 
proteins  
All buffers used for the purification of recombinant proteins were filtered through a 
0.22 μm membrane filter prior to use.  
Affinity chromatography buffers 
MBP Buffer : 30 mM Tris-HCl pH 7.4, 300 mM NaCl, 5% Glycerol, 1 mM EDTA  
Nickel A Buffer: 20 mM Tris-HCl pH 7.9, 500 mM NaCl, 10% glycerol,  
Nickel B Buffer: 20 mM Tris-HCl pH 7.9, 500 mM NaCl, 10% glycerol, 1 M 
imidazole  
charge solution: 0.1 M CoSO4 or 0.1 M NiSO4  
Ion exchange chromatography buffers  
Heparin Buffer A: 20 mM Hepes-NaOH pH 7, 50 mM NaCl 
Heparin Buffer B: 20 mM Hepes-NaOH pH 7, 1 M NaCl 
Heparin Buffer C: 50 mM Tris-HCl pH 7.4, 500 mM NaCl, 10% Glycerol 
Heparin Buffer D: 50 mM Tris-HCl pH 7.4, 2 M NaCl, 10% Glycerol 
Size exclusion chromatography buffers 
GF Buffer A: 30 mM Hepes-NaOH pH 7.5, 150 mM NaCl 
GF Buffer B: 30 mM Hepes pH 7.5, 300 mM NaCl, 10% Glycerol 
NMR filtration Buffer: 30 mM phosphate buffer pH 6.5, 150 mM NaCl 
 
TEV cleavage Buffer: 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 0.5 mM EDTA and 
10% glycerol  
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6x DNA loading Buffer: 50% (v/v) glycerol, 100 mM Na
2
EDTA·2H2O, 1% (w/v) 
SDS, 0.1% (w/v) bromophenol blue  
SDS-PAGE buffers  
2x SDS Sample Buffer: 0.125 M Tris-HCl, pH 6.8, 20% (v/v) glycerol, 0.04% (w/v) 
SDS, 10% (v/v) βME, 0.1% (w/v) bromophenol blue  
6x SDS Sample Buffer: 0.35 M Tris-HCl pH 6.8, 10% SDS, 30% glycerol, 9.3% 
DTT  
Tris Glycine SDS Separating gel solution: 0.375 M Tris-HCl, pH 8.8, 0.001% 
lauryl sulphate (SDS), , 10-15% Acrylamide/Bis, 0.0005% ammonium persulphate 
(APS) and 0.0001% N,N,N‟,N‟-tetramethylethylenediamine (TEMED).  
Tris Glycine SDS Stacking gel solution: 0.125 M Tris-HCl, pH 6.8, 0.001% SDS, , 
4% Acrylamide/Bis, 0.0005% APS and 0.0001% TEMED.  
10x Tris-glycine Buffer: 0.25 M Tris Base, 1.92 M Glycine, 10% SDS. The buffer 
was diluted 10-fold to use for electrophoresis.  
Tris Tricine SDS Separating gel solution: 1 M Tris-HCl, pH 8.5, 0.001% lauryl 
sulphate (SDS), , 10-15% Acrylamide/Bis, 0.0005% ammonium persulphate (APS) 
and 0.0001% N,N,N‟,N‟-tetramethylethylenediamine (TEMED).  
Tris Tricine SDS Stacking gel solution: 0.75 M Tris-HCl, pH 8.5, 0.001% SDS, , 
4% Acrylamide/Bis, 0.0005% APS and 0.0001% TEMED 
10X Cathode Buffer: 1 M Tris Base, 1 M Tricine, 1 % SDS 
10X Anode Buffer: 2 M Tris, pH 8.9 
Agarose gel buffer  
10x TBE: 890 mM Tris Base, 890 mM Boric Acid, 20 mM EDTA pH 85x DNA 
Sample Buffer:  0.1% xylene cyanol, 0.1% bromphenol blue, 50% glycerol 
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Other  
Primers: The cloning primers used in this study (Table 2.2) were supplied as 
desalted, lyophilised powders (Sigma-Genosys, UK). The primers used for site-
directed mutagenesis (Table 2.6) were purchased from MWG-Biotech (Germany). 
Primers were resuspended in deionised water to a final concentration of 100 μΜ. Α 
further dilution was made to produce a working stock of 10 μM. Stock solutions 
were stored at -20ºC.  
IPTG: IPTG powder (Carbosynth) was dissolved in deionised water to a final 
concentration of 1 M. The solution was filter sterilised, wrapped in foil and stored at 
-20ºC.  
PMSF: PMSF (Sigma Aldrich) powder was dissolved in ethanol to a final 
concentration of 100 mM. The stock was stored at 4ºC.  
AEBSF: PMSF (Sigma Aldrich) powder was dissolved in water  to a final 
concentration of 200 mM. The stock was stored at -20ºC.  
DTT: DTT powder (Sigma Aldrich) was dissolved in deionised water to a final 
concentration of 1 M. The solution was filter sterilised, divided in 1.5 ml aliquots and 
stored at -20ºC.  
Appendix 4 Experimental protocols 
107 
 
Appendix 4 Experimental protocols 
Protocol A – PCR  
Experimental conditions for the amplification of the genes and gene fragments listed in 
Table 
Reagent Volume Stock concentration 
Template DNA 1μl 
100-250ng/μl gen. DNA, 20-
25ng/μl of plasmid DNA 
dNTP mix 1μl  
10X Pfu Turbo polymerase buffer 5μl  
Primer reverse 1μl 10μM 
Primer forward 1μl 10μM 
Pfu Turbo polymerase 1μl  
Milli Q H2O 40μl  
 
PCR program  
5 min   initial denaturation at 94°C 
Then 10 cycles: 
45"   denaturation  94°C 
45"   annealing  45°C 
1'/kB   extension  72°C 
Then 35 cycles: 45" denaturation 94°C 
45"-1'   annealing   56°-68°C 
2-3'   extension  72°C 
then the final 8-10 min extension 
Protocol B – preparation of competent E. coli cells  
The following protocol was used for the preparation of the following E. coli strains from 
commercial original stocks: XL1-Blue (Stratagene), BL21(DE3) (Stratagene), BL21-
CodonPlus(DE3)-RIL (Stratagene) and B834(DE3) (Novagen) competent cells. The 
original stocks for each bacterial strain were kept in aliquots at -80ºC.  
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All media used for the preparation of XL1-Blue, BL21 (DE3) and B834 competent cells, 
were not supplemented with antibiotics. For the preparation of BL21-CodonPlus(DE3)-
RIL cells, however, 34 μg/ml chloramphenicol was added to all media. The 
compositions of buffers TFB1 and TFB2 that were used in this protocol are provided in 
Appendix 3.  
A trace of competent cells was removed from a stock vial with a sterile tip and streaked 
out on an agar plate and incubated at 37ºC overnight. Next, a single colony from the agar 
plate was inoculated in 10 ml LB medium and the culture was grown overnight at 37ºC 
with shaking at approximately 225 rpm. On the following day, 1 ml overnight culture 
was used to inoculate 100 ml prewarmed LB medium in a 250 ml flask. The cells were 
grown until an A
600nm 
of 0.5 was reached (typically 4 hr for XL1-Blue cells and 2 hr for 
the other three strains). The culture was cooled on ice for 5 min and then transferred to a 
sterile 50 ml Falcon tube. The cells were pelleted by centrifugation at 4000 g for 5 min at 
4ºC. The supernatant was carefully decanted and the cells were resuspended gently in 30 
ml cold (4ºC) TFB1 buffer and incubated on ice for 90 min. The cells were collected by 
centrifugation at 4000 g for 5 min at 4ºC and the supernatant was carefully decanted. 
Using chilled pipettes, the cells were gently resuspended in 4 ml ice-cold TFB2 buffer. 
200 μl aliquots of cells were prepared using prechilled sterile tubes. The aliquots were 
then frozen in a dry-ice/ethanol bath and stored at -80ºC.  
Protocol C – PCR-Based Site-Directed Mutagenesis  
All reactions were performed using the reagents provided in the QuikChange XL Site-
Directed Mutagenesis Kit (Stratagene), except for the dNTP mix, which was prepared 
from dNTPs purchased from New England Biolabs. The experimental conditions for the 
mutagenesis reactions which produced the mjElp3 cysteine mutants are the following:  
QuikSolution 3 μl  
reaction buffer 10x 10 μl  
primer #1 10 μM 125 ng  
primer #2 10 μM 125 ng 
dNTPs mix (12.5 mM)
* 
1 μl  
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template dsDNA
† 
25 ng  
Deionised water added to a final volume of 50 μl  
PfuTurbo polymerase 1 μl (2.5 U)  
The reactions were cycled using the following cycling parameters: 1 cycle at 95°C, for 1 
min; 18 cycles comprising 50 sec at 95°C, 50 sec at 60°C and 1.5 min/kb extension time 
at 68°C; 1 cycle and 68°C for 7 min. 
Protocol D – preparation of TEV protease  
The gene encoding the TEV protease was cloned into the expression vector pET24a 
(Novagen) that confers kanamycin resistance to the host cell, resulting in a recombinant 
protein with an C-terminal His-tag. The construct was used to transform E  coli BL21-
(DE3) Codon + RIPL cells. Cells were grown in Autoinduction TB medium 
(supplemented with kanamycin). Cells were grown for 24 hr at 25°C and then harvested 
by centrifugation at 3,000 g for 20 min at 4°C. The pellet was then stored at -80°C.  
Cell resuspension and protein purification were carried out according to the purification 
protocols described in Sections 2.2.1 and 2.2.2, using a Ni
2+ 
chelating column (5 ml, GE 
Healthcare). Fractions containing the rTEV protease were pooled and then the buffer was 
exchanged against 20 mM Tris-HCl pH 8, 500 mM NaCl, 1 mM βΜΕ and 10% glycerol. 
Protein samples were stored at -80°C. The final yield of purified rTEV protease was 
approximately 3 mg of protein per L of cell culture 
Protocol E – RT PCR   
First-Strand cDNA Synthesis 
A 20-μl reaction volume used for 1 ng–5 μg of total RNA  
 
1 μl oligo (dT)16 
1 μg total RNA  
1 μl 10 mM dNTP Mix ( 
Sterile, distilled water to 12 μl 
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2. Heat mixture to 65°C for 5 min and quick chill on ice. Collect the contents of the 
tube by brief centrifugation and add: 
4 μl 5X First-Strand Buffer 
2 μl 0.1 M DTT 
1 μl RNaseOUT Recombinant Ribonuclease Inhibitor (40 units/μl) 
 Mix contents of the tube gently and incubate at 37°C for 2 min. 
Add 1 μl (200 units) of M-MLV RT and mix by pipetting gently .  
Incubate 50 min at 37°C. 
Inactivate the reaction by heating at 70°C for 15 min. 
The cDNA can now be used as a template for amplification in PCR (protocol A) 
Protocol F – RF PCR 
Reagent Volume 
dNTP mix 1μl 
5X Phusion polymerase buffer (NEB) 10μl 
Megaprimer (2 µM) 1μl 
Vector (200 pM) 1μl 
Phusion polymerase  0.8 μl 
MgCl2 (50 mM) 2 μl 
Milli Q H2O Up to 50 μl 
 
PCR program  
30''   initial denaturation at 95°C 
Then 30 cycles: 
30"   denaturation  95°C 
1 min   annealing  60°C 
5 min   extension  72°C 
then the final 7 min extension 
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